<SEC-DOCUMENT>0001213900-24-026096.txt : 20240326
<SEC-HEADER>0001213900-24-026096.hdr.sgml : 20240326
<ACCEPTANCE-DATETIME>20240326171026
ACCESSION NUMBER:		0001213900-24-026096
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		19
FILED AS OF DATE:		20240326
DATE AS OF CHANGE:		20240326

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ACTELIS NETWORKS INC
		CENTRAL INDEX KEY:			0001141284
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMUNICATIONS EQUIPMENT, NEC [3669]
		ORGANIZATION NAME:           	04 Manufacturing
		IRS NUMBER:				522160309
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-276425
		FILM NUMBER:		24784611

	BUSINESS ADDRESS:	
		STREET 1:		4039 CLIPPER COURT
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
		BUSINESS PHONE:		510-545-1040

	MAIL ADDRESS:	
		STREET 1:		4039 CLIPPER COURT
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>ea0202475-s1a2_actelis.htm
<DESCRIPTION>AMENDMENT NO. 2 TO FORM S-1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 26 20:52:10 UTC 2024 -->
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:compsci="http://compsciresources.com" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:asns="http://www.actelisnetworksinc.com/20230930" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml">
<head>
     <title> </title>

<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font: 10pt Times New Roman, Times, Serif"><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b style="-keep: true">As filed with the United States Securities
and Exchange Commission on March 26, 2024.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><b>Registration No. 333-276425</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNITED STATES<br/>
SECURITIES AND EXCHANGE COMMISSION<br/>
Washington, D.C. 20549</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:AmendmentDescription" id="ixv-43"><b style="-keep: true">AMENDMENT NO. 2</b></ix:nonNumeric><b><br/>
TO<br/>
FORM <span style="-sec-ix-hidden: hidden-fact-0">S-1</span><br/>
REGISTRATION STATEMENT<br/>
UNDER<br/>
THE SECURITIES ACT OF 1933</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-67"><b>Actelis Networks, Inc.</b></ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>(Exact Name of Registrant as Specified in Its
Charter)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; width: 32%; padding-right: 3pt; text-align: center"><ix:nonNumeric contextRef="c0" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="ixv-91"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Delaware</b></span></ix:nonNumeric></td> <td style="white-space: nowrap; width: 2%; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3669</b></span></td> <td style="white-space: nowrap; width: 2%; padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>52-2160309</b></span></td></tr> <tr style="vertical-align: top"> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(State or Other Jurisdiction of<br/>
Incorporation or Organization)</i></span></td> <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(Primary Standard Industrial <br/>
Classification Code Number)</i></span></td> <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td> <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>(I.R.S.&#160;Employer<br/>
Identification Number)</i></span></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Actelis Networks, Inc.<br/>
4039 Clipper Court<br/>
Fremont, CA 94538<br/>
(510)&#160;545-1045</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><i>(Address, Including Zip Code, and Telephone
Number, Including Area Code, of Registrant&#8217;s Principal Executive Offices)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Tuvia Barlev<br/>
Chief Executive Officer and Chairman of the Board of Directors<br/>
Actelis Networks, Inc.<br/>
4039 Clipper Court<br/>
Fremont, CA 94538<br/>
(510)&#160;545-1045<br/>
</b><i>(Name, Address, Including Zip Code, and Telephone Number, Including Area Code, of Agent For Service)</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Copies to:</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b style="-keep: true">Eyal Peled, Esq.</b><b><br/>
<span style="-keep: true">Greenberg Traurig LLP</span><br/>
<span style="-keep: true">One Vanderbilt Avenue,</span><br/>
<span style="-keep: true">New York, New York 10017</span><br/>
<span style="-keep: true">Phone: (212) 801-9210</span><br/>
<span style="-keep: true">Fax: (212) 801-6400</span></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Approximate date of commencement
of proposed sale to the public: </b>As soon as practicable after the effective date of this registration statement.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If any of the securities being
registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule&#160;415 under the Securities Act&#160;of&#160;1933
check the following box. &#9746;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If this Form is filed to register
additional securities for an offering pursuant to Rule&#160;462(b)&#160;under the Securities Act, please check the following box and list
the Securities Act registration statement number of the earlier effective registration statement for the same offering. &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If this Form is a post-effective
amendment filed pursuant to Rule&#160;462(c)&#160;under the Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering. &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If this Form is a post-effective
amendment filed pursuant to Rule&#160;462(d)&#160;under the Securities Act, check the following box and list the Securities Act registration
statement number of the earlier effective registration statement for the same offering. &#9744;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Indicate by check mark whether
the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging
growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting
company,&#8221; and &#8220;emerging growth company&#8221; in Rule&#160;12b-2 of the Exchange&#160;Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: top"> <td style="width: 3%; padding-bottom: 2.25pt">&#160;</td> <td style="white-space: nowrap; width: 1%; padding-bottom: 2.25pt">&#160;</td> <td style="width: 16%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Large&#160;accelerated&#160;filer</span></td> <td style="white-space: nowrap; width: 1%; padding-bottom: 2.25pt">&#160;</td> <td style="width: 25%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td> <td style="white-space: nowrap; width: 1%; padding-bottom: 2.25pt">&#160;</td> <td style="width: 19%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accelerated&#160;filer</span></td> <td style="white-space: nowrap; width: 1%; padding-bottom: 2.25pt">&#160;</td> <td style="width: 33%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td></tr> <tr style="vertical-align: top"> <td style="padding-bottom: 2.25pt">&#160;</td> <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td> <td><ix:nonNumeric contextRef="c0" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="ixv-240"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-accelerated&#160;filer</span></ix:nonNumeric></td> <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td> <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Smaller&#160;reporting&#160;company</span></td> <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td> <td style="text-align: justify"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntitySmallBusiness" id="ixv-250"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr> <tr style="vertical-align: top"> <td style="padding-bottom: 2.25pt">&#160;</td> <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td> <td style="padding-bottom: 2.25pt">&#160;</td> <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td> <td style="padding-bottom: 2.25pt">&#160;</td> <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td> <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Emerging&#160;growth&#160;company</span></td> <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td> <td style="text-align: justify"><ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="dei:EntityEmergingGrowthCompany" id="ixv-263"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></ix:nonNumeric></td></tr> </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If an emerging growth company,
indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section&#160;7(a)(2)(B)&#160;of the Securities Act. <ix:nonNumeric contextRef="c0" format="ixt:fixed-false" name="dei:EntityExTransitionPeriod" id="ixv-3452">&#9744;</ix:nonNumeric></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>The Registrant hereby amends
this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further
amendment which specifically states that this Registration Statement shall thereafter become effective in accordance with Section&#160;8(a)&#160;of
the Securities Act&#160;of&#160;1933, as amended, or until the Registration Statement shall become effective on such date as the Securities
and Exchange Commission, acting pursuant to said Section&#160;8(a), may determine.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="color: Red"><b>The information in
this preliminary prospectus is not complete and may be changed. We may not sell these securities until the registration statement filed
with the Securities and Exchange Commission is effective. This preliminary prospectus is not an offer to sell these securities and it
is not soliciting an offer to buy these securities in any jurisdiction where the offer or sale is not permitted.</b></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 32%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="color: Red"><b>PRELIMINARY PROSPECTUS</b></span></p></td>
    <td style="white-space: nowrap; width: 1%"><span style="color: Red">&#160;</span></td>
    <td style="width: 67%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: Red"><b>SUBJECT
    TO COMPLETION DATED MARCH 26, 2024</b></span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><img alt="" src="image_001.jpg"/>&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Actelis Networks, Inc.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b style="-keep: true">3,697,154&#160;Shares of Common Stock</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif">This
prospectus relates to the </span>resale, by the selling stockholders identified in this prospectus, of up to an aggregate of up to 3,697,154
shares of common stock, $0.0001 par value of Actelis Network, Inc., consisting of (i) 301,000 shares of common stock issued in a private
placement in December 2023, or the December 2023 Private Placement, (ii) 1,271,187 shares of common stock issuable upon the exercise
of warrants issued in the December 2023 Private Placement, (iii) 970,187 shares of common stock issuable upon the exercise of pre-funded
warrants issued in the December 2023 Private Placement, (iv) 55,000 shares of common stock issuable upon the exercise of warrants issued
in September 2023, (v) 944,670 shares of common stock issuable upon the exercise of warrants issued in a private placement in May 2023,
or the May 2023 Private Placement, (vi) 88,983 shares of common stock issuable upon the exercise of placement agent warrants issued in
connection with the December 2023 Private Placement, and (vii) 66,127 shares of common stock issuable upon the exercise of placement
agent warrants issued in connection with the May 2023 Private Placement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">We are not selling any
common stock under this prospectus and will not receive any of the proceeds from the sale or other disposition of shares by any of the
selling stockholders, however, we will receive proceeds from the exercise of any Warrants for cash.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">The selling
stockholders or its transferees, pledgees, assignees, or successors-in-interest may offer and sell or otherwise dispose of the
shares of common stock described in this prospectus from time to time through public or private transactions at prevailing market
prices, at prices related to prevailing market prices or at privately negotiated prices. The selling stockholder will bear all
commissions and discounts, if any, attributable to the sales of shares. We will bear all other costs, expenses, and fees in
connection with the registration of the shares. See &#8220;Plan of Distribution&#8221; beginning on page 15 for more information
about how a selling stockholder may sell or dispose of the shares of Common Stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">Our common stock is traded
on the Nasdaq Capital Market under the symbol &#8220;ASNS.&#8221; On March 22, 2024, the closing price of our common stock on the Nasdaq
Capital Market was $1.06 per share.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b style="-keep: true">Investing in our securities
involves a high degree of risk. You should read this prospectus supplement and the accompanying prospectus as well as the information
incorporated herein and therein by reference carefully before you make your investment decision. See &#8220;Risk Factors&#8221; beginning
on page 6 of this prospectus.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>Neither the Securities and
Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus
is truthful or complete. Any representation to the contrary is a criminal offense.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.5in"><span style="-keep: true">The date of this prospectus
is &#160;&#160;March &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;, 2024.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 2 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>TABLE OF CONTENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; width: 89%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="padding-bottom: 1.5pt; white-space: nowrap; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><a href="#a_001"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">About this Prospectus</span></a></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center">ii</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><a href="#a_002"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cautionary Note Regarding Forward-Looking Statements</span></a></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><a href="#a_003"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prospectus Summary</span></a></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center">1</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><a href="#a_004"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk Factors</span></a></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center">6</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><a href="#a_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of Proceeds</span></a></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td><a href="#a_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Selling Stockholders</span></a></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><a href="#a_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Description of Offered Securities</span></a></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center">10</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><a href="#a_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan of Distribution</span></a></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">15</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><a href="#a_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Legal Matters</span></a></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center">16</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><a href="#a_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Experts</span></a></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center">16</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><a href="#a_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Where You Can Find More Information</span></a></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center">16</td></tr>
  <tr style="vertical-align: bottom; ">
    <td><a href="#a_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incorporation by Reference</span></a></td>
    <td style="white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="text-align: center">18<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 3; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->i<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_001"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>ABOUT THIS PROSPECTUS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">This prospectus is part
of a registration statement that we filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;). The selling stockholders
named in this prospectus may from time to time sell the securities described in the prospectus. You should read this prospectus together
with the more detailed information regarding our company, our Common stock, and our financial statements and notes to those statements
that appear elsewhere in this prospectus and any applicable prospectus supplement together with the additional information that we incorporate
in this prospectus by reference, which we describe under the heading &#8220;Where You Can Find More Information.&#8221;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">You should rely only on the
information contained in, or incorporated by reference in, this prospectus and in any accompanying prospectus supplement. We have not
authorized anyone to provide you with different information from that contained in, or incorporated by reference in, this prospectus.
You should not assume that the information in this prospectus or any prospectus supplement is accurate as of any date other than the date
on the front of those documents or that any document incorporated by reference is accurate as of any date other than its filing date.
You should not consider this prospectus to be an offer or solicitation relating to the securities in any jurisdiction in which such an
offer or solicitation relating to the securities is not authorized. Furthermore, you should not consider this prospectus to be an offer
or solicitation relating to the securities if the person making the offer or solicitation is not qualified to do so, or if it is unlawful
for you to receive such an offer or solicitation.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In this prospectus, we frequently
use the terms &#8220;we,&#8221; &#8220;our,&#8221; &#8220;us,&#8221; &#8220;our company,&#8221; and the &#8220;Company&#8221; to refer
to Actelis Networks, Inc.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>




</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p><div>

</div><!-- Field: Page; Sequence: 4; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_002"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b style="-keep: true">CAUTIONARY NOTE REGARDING FORWARD-LOOKING
STATEMENTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">This prospectus and the documents
incorporated by reference herein contain certain &#8220;forward-looking statements&#8221; within the meaning of the Private Securities
Litigation Reform Act&#160;of&#160;1995, Section&#160;27A of the Securities Act&#160;of&#160;1933, as amended (the &#8220;Securities Act&#8221;),
and Section&#160;21E of the Securities Exchange&#160;Act&#160;of&#160;1934, as amended (the Exchange&#160;Act&#8221;). We have tried,
whenever possible, to identify these forward-looking statements using words such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221;
&#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;anticipate,&#8221; &#8220;intend,&#8221; &#8220;continue,&#8221; &#8220;plan,&#8221;
&#8220;predict,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;potential,&#8221; &#8220;ongoing,&#8221;
and similar expressions to identify forward-looking statements, whether in the negative or the affirmative. These statements reflect our
current beliefs and are based on information currently available to us. Accordingly, such forward-looking statements involve known and
unknown risks, uncertainties and other factors which could cause our actual results, performance or achievements to differ materially
from those expressed in, or implied by, such statements. Forward-looking statements contained herein include, but are not limited to,
statements about:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">our history of losses and need for additional capital to fund
our operations and our ability to obtain additional capital on acceptable terms, or at all;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">our ability to protect our intellectual property and continue
to innovate;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">our success in retaining or recruiting, or changes required
in, our officers, key employees or directors;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the potential insufficiency of our disclosure controls and
procedures to detect errors or acts of fraud;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the accuracy of our estimates regarding expenses, future revenues,
and capital requirements;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">the success of competing products or technologies that are
or may become available;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">our ability to grow the business due to the uncertainty resulting
from the COVID-19 pandemic or any future pandemic;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">our ability to comply with complex and increasing regulations
by governmental authorities;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">our ability
                                            to regain and maintain compliance with continued listing requirements of the Nasdaq Capital
                                            Market;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">our ability
                                            to continue as a going concern;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">statements as
                                            to the impact of the political and security situations in Israel on our business, including
                                            due to the number of armed conflicts between Israel and Hamas (an Islamist militia and political
                                            group in the Gaza Strip) and Hezbollah (an Islamist militia and political group in Lebanon);</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">our public securities&#8217; potential liquidity and trading;
and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">our expectations regarding the period during which we qualify
as an emerging growth company under the JOBS Act.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Forward-looking statements
are based on our management&#8217;s current expectations, estimates, forecasts and projections about our business and the industry in
which we operate and our management&#8217;s beliefs and assumptions, and are not guarantees of future performance or development and involve
known and unknown risks, uncertainties and other factors that are in some cases beyond our control. As a result, any or all of our forward-looking
statements herein may turn out to be inaccurate. Important factors that may cause actual results to differ materially from current expectations
include, among other things, those listed under &#8220;Risk Factors,&#8221; Use of Discussion and Analysis of Financial Condition and
Results of Operations,&#8221; &#8220;Business&#8221; and elsewhere herein or by incorporation by reference. Potential investors are urged
to consider these factors carefully in evaluating the forward-looking statements. You should read thoroughly this prospectus and the documents
that we refer to with the understanding that our actual future results may be materially different from and worse than what we expect.
We qualify all of our forward-looking statements by these cautionary statements.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The forward-looking statements
included in this prospectus speak only as of the date of this prospectus. Although we believe that the expectations reflected in the forward-looking
statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected
in the forward-looking statements will be achieved or will occur. Except as required by law, we assume no obligation to update or revise
these forward-looking statements for any reason, even if new information becomes available in the future. You should, however, review
the factors and risks we describe in the reports we will file from time to time with the SEC after the date of this prospectus. See &#8220;Where
You Can Find More Information.&#8221;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">On April 19, 2023, we
effected a reverse stock split of our shares of common stock at the ration of 1-for-10. Unless indicated otherwise by the context, all
common stock, option, warrant and per share amounts, as well as share prices appearing in this prospectus have been adjusted to give
retroactive effect to the stock split for all periods presented.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 5; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="padding: 5.4pt; border: Black 1.5pt solid; width: 98%">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<a id="a_003"></a><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PROSPECTUS SUMMARY</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>This summary highlights
information contained elsewhere in this prospectus. Because this is only a summary, it does not contain all of the information that may
be important to you. You should read this entire prospectus and should consider, among other things, the matters set forth under &#8220;Risk
Factors,&#8221; &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our consolidated
financial statements and related notes thereto appearing elsewhere in this prospectus before making your investment decision. This prospectus
contains forward-looking statements and information relating to Actelis Networks, Inc. See &#8220;Cautionary Note Regarding Forward-Looking
Statements&#8221; on page iii</i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">Actelis Networks, Inc.
(&#8220;we&#8221;, &#8220;the Company&#8221;, &#8220;Actelis&#8221;, &#8220;us&#8221;, &#8220;our&#8221;) is a market leader in cyber-hardened,
rapid-deployment networking solutions for wide-area IoT applications including federal, state and local government, intelligent traffic
systems (&#8220;ITS&#8221;), military, utility, rail, telecom and campus applications. Our unique portfolio of hybrid fiber, environmentally
hardened aggregation switches, high density Ethernet devices, advanced management software and cyber-protection capabilities, unlocks
the hidden value of essential networks, delivering safer connectivity for rapid, cost-effective deployment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">Our networking solutions
use a combination of newly deployed fiber infrastructure and existing copper and coaxial lines which our patented technology can upgrade
to Fiber-grade to jointly create what we believe to be a highly cost-effective, secure, and quick-to-deploy network. Our patent protected
hybrid fiber networking solutions deliver excellent communication over fiber to locations that may be easy to reach with new fiber. However,
for locations that are difficult, or too costly to reach with fiber, we can upgrade existing copper lines to deliver cyber-hardened,
high-speed connectivity without needing to replace the existing copper infrastructure with new fiber. We believe that such hybrid fiber
copper networking solution has distinct advantages in most real-life installations, while providing significant budget savings and accelerating
deployment of modern IoT networks, as based on our experience, most IoT&#160;projects have challenging, hard to reach with fiber locations
which may explode such projects&#8217; timeline and budgets. We believe that our solutions can provide connectivity over either fiber
or copper with speeds of up to multi-Gigabit communication, while supporting Fiber-grade reliability and quality.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">A primary focus of ours
is to provide our customers with a cyber-secure network solution. We currently offer Triple-Shield protection of data delivered with
coding, scrambling and encryption of the network traffic. We also provide secure, encrypted access to our network management software,
and are working to further enhance system-level and device-level software protection. We are also working to introduce additional capabilities
for network-wide cyber protection software as an additional SW and license-based services.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">When high speed, long
reach, reliable and secure connectivity is required, network operators usually resort to using wireline communication over physical communication
lines such as fiber, coax, and copper, rather than wireless communication that is more limited in performance, reliability, reach and
security. However, new fiber wireline infrastructure is costly to deploy, involves lengthy civil works to install, and, based on our
internal calculations, often accounts for more than 50% of total cost of ownership (ToC) and time to deploy wide-area IoT projects.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">Providing new fiber connectivity
to hard-to-reach locations is especially costly and time-consuming, often requiring permits for boring, trenching, and right-of-way,
sometimes done over many miles. Connecting such hard-to-reach locations may cause significant delays and budget overruns in IoT projects.
Our solutions aim to solve these challenges by instantly enhancing performance of such existing copper and coax infrastructure to fiber-grade
performance, through the use of advanced signal processing and unique, patented network architecture, without the need to run new fiber
to hard-to-reach locations; thus, effectively accelerating deployment of many IoT projects, as we estimate, sometimes from many&#160;months
to only&#160;days. The result for the network owner is a hybrid network that optimizes the use of both new Fiber (where available) as
well as upgraded, fiber-grade copper and coax that is now modernized, digitized and cyber-hardened. This unique hybrid network approach
is making IoT projects often significantly more affordable, fast to deploy and predictable to plan and budget.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 6; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="padding: 5.4pt; border: Black 1.5pt solid; width: 98%">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, our solutions
can also provide power over existing copper and coax lines to remotely power up network elements and IoT components connected to them
(like cameras, small cell and Wi-Fi base stations sensors etc.). Connecting power lines to millions of IoT locations can be costly and
very time consuming as well (similar to data connectivity, for the same reason&#160;&#8212;&#160;need for civil works). By offering the
ability to combine power delivery over the same existing copper and coax lines that we use for high-speed data, we believe our solutions
are solving yet another important challenge in connecting hard-to-reach locations. We believe that combining communication and power over
the same existing lines is particularly important to help connect many fifth generation, or 5G, small cells and Wi-Fi base stations, as
high cost of connectivity and power is often slowing their deployment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">Since our inception, our
business has been focused on serving telecommunication service providers, also known as Telcos, to provide connectivity for enterprises
and residential customers. Our products and solutions have been deployed with more than 100 telecommunication service providers worldwide,
in enterprise, residential and mobile base station connectivity applications. In recent&#160;years, as we have further developed our
technology and introduced additional products, we turned our focus on serving the wide-area IoT markets. Our operations are focused on
our fast-growing IoT business, while maintaining our commitment to our existing Telco customers. In 2023, we introduced new product offerings,
some of which could serve both the IoT markets and our Telco customers.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b style="-keep: true">May 2023 Private Placement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif">On
May 4, 2023, we entered into a securities purchase agreement with an accredited investor (the &#8220;Investor&#8221;), pursuant to which
we sold to the Investor in a private placement (i) 190,000 shares of common stock, (ii) 754,670 pre-funded warrants to purchase up to
754,670 shares of common stock and (iii) warrants to purchase up to 944,670 shares of common stock, for a purchase price of $3.705 per
share of common stock and related Common Warrant, or $3.7049 per pre-funded warrant and related common warrant, for a total aggregate
gross proceeds of approximately $3.5 million. The May</span> 2023 Private Placement <span style="font-family: Times New Roman, Times, Serif">closed
on May 8, 2023. The common warrants had an exercise price of $3.58 per share, are exercisable immediately upon issuance and expire five
and one-half years following the issuance. The pre-funded warrants are exercisable immediately upon issuance, have an exercise price
of $0.0001 per share and expire when exercised in full.</span></span><span style="font-family: Times New Roman, Times, Serif"> </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif">We
paid to H.C.&#160;Wainwright&#160;&amp; Co., LLC, the placement agent, an aggregate cash fee equal to 7.0% of the gross proceeds received
by us from the offering in placement agent fees, a management fee equal to 1.0% of the gross proceeds raised in the offering, a non-accountable
expense allowance of $65,000 and a management fee equal to 1.0% of the gross proceeds raised in the </span>offering<span style="font-family: Times New Roman, Times, Serif">.
We also issued unregistered placement agent warrants to purchase up to an aggregate of 88,983 ordinary shares at an exercise price per
share of $1.475 and a term of five and one-half&#160;years.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">In connection with the
May 2023 Private Placement, the selling shareholders named in this prospectus may offer and sell up to an aggregate of 1,010,797 shares
of common stock, including shares issuable upon exercise of warrants and pre-funded warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 7; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="padding: 5.4pt; border: Black 1.5pt solid; width: 98%">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b style="-keep: true">September 2023 Warrant Amendment</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">On September 30, 2023,
we entered into a common warrants amendment agreement (the &#8220;September 2023 Amendment&#8221;) with the Investor to amend those common
warrants to purchase up to 944,670 shares issued to the Investor as part of the May 2023 Private Placement. The Amendment reduced the
exercise price of the common warrants to $2.75 per share, and made certain adjustment to the definition of a &#8220;Fundamental Transaction&#8221;
in the common warrants. In addition, the Amendment resulted in the issuance of an additional 55,000 common warrants to the Investor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">In connection with the
September 2023 Amendment, the selling shareholders named in this prospectus may offer and sell up to an aggregate of 55,000 shares of
common stock issuable upon exercise of warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b style="-keep: true">December 2023 Private Placement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif">On
December 17, 2023, we entered into a securities purchase agreement with the Investor, pursuant to which we sold to the Investor in a
private placement (i) 301,000 shares of common stock, (ii) 970,187 pre-funded warrants to purchase up to 970,187 shares of common stock
and (iii) common warrants to purchase up to 1,271,187 shares of common stock, for a purchase price of $1.18 per share of common stock
and related common warrant, or $1.1799 per pre-funded warrant and related common warrant, for a total aggregate gross proceeds of approximately
$1.5 million. The </span>December 2023 Private Placement <span style="font-family: Times New Roman, Times, Serif">closed on December
20, 2023.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">The common warrants have
an exercise price of $1.18 per share, are exercisable commencing on the effective date of shareholder approval of the issuance of the
shares issuable upon exercise of the common warrants and expire five and one-half years following the issuance. The pre-funded warrants
are exercisable immediately upon issuance, have an exercise price of $0.0001 per share, and expire when exercised in full.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif">We
paid to H.C.&#160;Wainwright&#160;&amp; Co., LLC, the placement agent, an aggregate cash fee equal to 7.0% of the gross proceeds received
by us from the offering in placement agent fees, a management fee equal to 1.0% of the gross proceeds raised in the offering, a non-accountable
expense allowance of $35,000 and a management fee equal to 1.0% of the gross proceeds raised in the </span>offering<span style="font-family: Times New Roman, Times, Serif">.
We also issued unregistered placement agent warrants to purchase up to an aggregate of 88,983 ordinary shares at an exercise price per
share of $1.475 and a term of five and one-half&#160;years.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">In connection with the
December 2023 Private Placement, the selling shareholders named in this prospectus may offer and sell up to an aggregate of 2,631,357
shares of common stock, including shares issuable upon exercise of warrants and pre-funded warrants.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b style="-keep: true">Recent Developments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i style="-keep: true">Nasdaq Listing Compliance</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">On August 25, 2023, we
received a notification letter from the Listing Qualifications Department of the Nasdaq Stock Market LLC indicating that we are not in
compliance with Nasdaq Listing Rule 5550(b)(1) due to our failure to maintain a minimum of $2,500,000 in shareholders&#8217; equity (the
&#8220;Minimum Shareholders&#8217; Equity Requirement&#8221;) or any alternatives to such requirement. In order to maintain our listing
on the Nasdaq Capital Market, we submitted a plan of compliance addressing how we intended to regain compliance. We had until February
21, 2024 to evidence compliance with the Minimum Shareholders&#8217; Equity Requirement. As of the date of this Annual Report, we have
not provided such evidence. In the event that our shares of common stock would be subject to delisting, we intend to timely request a
hearing before the Nasdaq Hearings Panel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 8; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="padding: 5.4pt; border: Black 1.5pt solid; width: 98%">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>JOBS Act and the Implications of Being an Emerging
Growth Company and a Smaller Reporting Company</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We qualify as an &#8220;emerging
growth company&#8221; as defined in the Jumpstart Our Business Startups Act&#160;of&#160;2012, as amended, or the JOBS Act. As an &#8220;emerging
growth company,&#8221; we may take advantage of specified reduced disclosure and other requirements that are otherwise applicable generally
to public companies. These provisions include, but are not limited to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">requiring only two&#160;years of audited financial statements
in addition to any required unaudited interim financial statements with correspondingly reduced &#8220;Management&#8217;s discussion
and analysis of financial condition and results of operations&#8221; in our Securities Act&#160;of&#160;1933, as amended, or the Securities
Act, filings;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">reduced disclosure about our executive compensation arrangements;</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">no non-binding advisory votes on executive compensation or
golden parachute arrangements; and</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">exemption from compliance with the auditor attestation requirement
in the assessment of our internal control over financial reporting pursuant to Section&#160;404(b)&#160;of the Sarbanes Oxley Act&#160;of&#160;2002,
or SOX.</td>
</tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">We may take advantage
of these exemptions for up to five&#160;years or such earlier time that we are no longer an &#8220;emerging growth company.&#8221; We
will continue to remain an &#8220;emerging growth company&#8221; until the earliest of the following: (i)&#160;the last&#160;day of the
fiscal year following the fifth anniversary of our first sale of our common equity securities pursuant to an effective registration statement
(i.e. December 31, 2027); (ii)&#160;the last&#160;day of the fiscal year in which our total annual gross revenue is equal to or more
than $1.235&#160;billion; (iii)&#160;the date on which we have issued more than $1&#160;billion in nonconvertible debt during the previous
three&#160;years; or (iv)&#160;the date on which we are deemed to be a large accelerated filer under the rules&#160;of the Securities
and Exchange Commission, or the SEC.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are also a &#8220;smaller
reporting company&#8221; as defined in the Securities Exchange&#160;Act&#160;of&#160;1934, as amended, or the Exchange&#160;Act, and have
elected to take advantage of certain of the scaled disclosures available to smaller reporting companies. To the extent that we continue
to qualify as a &#8220;smaller reporting company&#8221; as such term is defined in Rule&#160;12b-2 the Exchange&#160;Act, after we cease
to qualify as an emerging growth company, certain of the exemptions available to us as an &#8220;emerging growth company&#8221; may continue
to be available to us as a &#8220;smaller reporting company,&#8221; including exemption from compliance with the auditor attestation requirements
pursuant to SOX and reduced disclosure about our executive compensation arrangements. We will continue to be a &#8220;smaller reporting
company&#8221; until we have $250&#160;million or more in public float (based on our common stock) measured as of the last business&#160;day
of our most recently completed second fiscal quarter or, in the event we have no public float (based on our common stock) or a public
float (based on our common stock) that is less than $700&#160;million, annual revenues of $100&#160;million or more during the most recently
completed fiscal year.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We may choose to take advantage
of some, but not all, of these exemptions. We have taken advantage of reduced reporting requirements in this prospectus. Accordingly,
the information contained herein may be different from the information you receive from other public companies in which you hold stock.
In addition, the JOBS Act provides that an emerging growth company may take advantage of an extended transition period for complying with
new or revised accounting standards, delaying the adoption of these accounting standards until they would apply to private companies.
We have elected to avail ourselves of the extended transition period for complying with new or revised financial accounting standards.
As a result of this accounting standards election, we will not be subject to the same implementation timing for new or revised accounting
standards as other public companies that are not emerging growth companies which may make comparison of our financials to those of other
public companies more difficult.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 9; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><div style="padding: 5.4pt; border: Black 1.5pt solid; width: 98%">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>THE OFFERING</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 34%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stock by the Selling Stockholders</span></td>
    <td style="white-space: nowrap; width: 2%"><span style="-keep: true">&#160;</span></td>
    <td style="width: 64%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,697,154
    shares of Common Stock, consisting of (i)&#160;301,000 shares of </span><span style="font-size: 10pt">common stock issued
    in the December 2023 Private Placement, (ii) 1,271,187 shares of common stock issuable upon the exercise of warrants issued in the
    December 2023 Private Placement, (iii) 970,187 shares of common stock issuable upon the exercise of pre-funded warrants issued in
    the December 2023 Private Placement, (iv) 55,000 shares of common stock issuable upon the exercise of warrants issued in September
    2023, (v) 944,670 shares of common stock issuable upon the exercise of warrants issued in a private placement in the May 2023 Private
    Placement, (vi) 88,983 shares of common stock issuable upon the exercise of placement agent warrants issued in connection with the
    December 2023 Private Placement, and (vii) 66,127 shares of common stock issuable upon the exercise of placement agent warrants issued
    in connection with the May 2023 Private Placement.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Plan of Distribution</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The selling stockholders will determine when and how they will sell the common stock covered by this prospectus. See the &#8220;Plan of Distribution&#8221; section of this prospectus.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of Proceeds</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We will not receive
    any proceeds from the sale of the Common Stock by the selling stockholders. All net proceeds from the sale of the Common Stock covered
    by this prospectus will go to the selling stockholders. However, we may receive the proceeds from any exercise of warrants if the
    selling stockholders do not exercise their warrants on a cashless basis, if and when exercised. See the section of this prospectus
    titled &#8220;Use of Proceeds.&#8221;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk factors</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">See &#8220;Risk Factors&#8221; and other information appearing elsewhere in this prospectus for a discussion of factors you should carefully consider before deciding whether to invest in our securities.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Listing</span></td>
    <td style="white-space: nowrap">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our common stock is listed on the Nasdaq Capital Market under the symbol &#8220;ASNS.&#8221;</span></td></tr>
  </table>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b style="-keep: true">Corporate Information</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">We were incorporated in
Delaware in 1998. We completed our initial public offering on May 17, 2022 and our common stock is currently listed on the Nasdaq Global
Select Market under the symbol &#8220;ASNS.&#8221; Our principal executive offices are located at 4039 Clipper Court, Fremont, CA 94538,
and our telephone number is (510)-545-1040. The information contained on our website and available through our website is not incorporated
by reference into and should not be considered a part of this prospectus, and the reference to our website in this prospectus is an inactive
textual reference only.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p>

</div><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Page; Sequence: 10; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_004"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>RISK FACTORS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">An investment in our securities
involves a high degree of risk. You should carefully consider the risk factors set forth in our most recent Annual Report on Form 10-K
on file with the SEC, which is incorporated by reference into this prospectus, as well as the following risk factors, which supplement
or augment the risk factors set forth in our Annual Report on Form 10-K. Before making an investment decision, you should carefully consider
these risks as well as other information we include or incorporate by reference in this prospectus. The risks and uncertainties not presently
known to us or that we currently deem immaterial may also materially harm our business, operating results and financial condition and
could result in a complete loss of your investment.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b><i>Sales of substantial
amounts of our Common Stock by a selling stockholder, or the perception that these sales could occur, could adversely affect the price
of our Common Stock.</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The sale by the selling stockholders
of a significant number of shares of Common Stock could have a material adverse effect on the market price of our Common Stock. In addition,
the perception in the public markets that the selling stockholder may sell all or a portion of its shares as a result of the registration
of such shares for resale pursuant to this prospectus could also in and of itself have a material adverse effect on the market price of
our Common Stock. We cannot predict the effect, if any, that market sales of those shares of Common Stock or the availability of those
shares of Common Stock for sale will have on the market price of our Common Stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 11; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><div><a id="a_005"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b style="-keep: true">USE OF PROCEEDS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">We are not selling any
Common Stock under this Prospectus and w<span style="font-family: Times New Roman, Times, Serif">e will not receive any proceeds from
the sale of the Common Stock by the selling stockholders. All net proceeds from the sale of the Common Stock covered by this prospectus
will go to the selling stockholders. We expect that the selling stockholders will sell their Common Stock as described under &#8220;Plan
of Distribution.&#8221;</span></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">We
may receive proceeds from the exercise of the warrants to the extent that these warrants are exercised for cash by the selling stockholders.
Warrants, however, are exercisable on a cashless basis under certain circumstances. If all of the warrants mentioned above were exercised
for cash in full, the gross proceeds would be approximately $2.7 million. We intend to use the net proceeds of such warrant exercise,
if any, for general corporate purposes. Pending such uses, we intend to invest the net proceeds in bank deposits. We can make no assurances
that any of the warrants will be exercised, or if exercised, that they will be exercised for cash, the quantity which will be exercised
or in the period in which they will be exercised.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 12; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><div><a id="a_006"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SELLING STOCKHOLDERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Common Stock being offered
by each of the selling stockholders are those previously issued to the selling stockholders, and those issuable to the selling stockholders,
upon exercise of either the Placement Agent Warrants, Common Warrants or Pre-Funded Warrants. For additional information regarding the
issuances of those shares of Common Stock and Placement Agent Warrants, Common Stock Warrants and Pre-Funded Warrants, see the description
of the Private Placement in &#8220;<i>Prospectus Summary&#160;&#8212;&#160;Private Placement</i>&#8221; above. We are registering the
shares of Shares in order to permit the selling stockholders to offer the shares for resale from time to time. None of the selling stockholders
have had any material relationship with us within the past three&#160;years.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">The table below lists
the selling stockholders and other information regarding the beneficial ownership of the shares of Common Stock by each of the selling
stockholders. The second column lists the number of shares of Common Stock beneficially owned by each selling stockholder, based on its
ownership of the shares of Common Stock and the warrants, as of March 22, 2024, assuming exercise of the warrants (either the Common
Stock Warrants or the Placement Agent Warrants) held by the selling stockholders on that date, without regard to any limitations on exercises.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The third column lists the
shares of Common Stock being offered by this prospectus by each of the selling stockholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In accordance with the terms
of a Registration Rights Agreement with the Investor, this prospectus generally covers the resale of the sum of (i)&#160;Shares; (ii)&#160;Pre-Funded
Warrant Shares and (iii)&#160;Common Warrant Shares. The table below assumes that the outstanding Pre-Funded Warrants, Common Warrants
and the Placement Agent Warrants were exercised in full as of the&#160;trading day immediately preceding the date this registration statement
was initially filed with the SEC, each as of the&#160;trading day immediately preceding the applicable date of determination, without
regard to any limitations on the exercise thereof. The fourth column assumes the sale of all of the shares of common stock offered by
the selling stockholders pursuant to this prospectus. The fifth column lists the percentages of shares of common stock owned by each selling
stockholders after this offering, taking account of any limitations on exercise set forth in the applicable Securities.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif">Under
the terms of the Private Placement Warrants, a selling stockholder may not exercise the Private Placement Warrants to the extent such
exercise would cause such selling stockholder, together with its affiliates and attribution parties, to beneficially own a number of
shares of common stock which would exceed 4.99% or 9.99% of our then outstanding common stock following such exercise, excluding for
purposes of such determination shares of common stock issuable upon exercise of the Private Placement Warrants which have not been exercised.
The number of shares in the second column does not reflect this limitation. The selling stockholders may sell all, some or none of their
shares in this offering. See &#8220;<i>Plan of Distribution</i>.&#8221; The total number of outstanding shares of common stock as of
March 20, 2024 was </span>3,020,268, including treasury shares.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: left; font-weight: bold"><span style="-keep: true">Name of selling stockholder</span></td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"><span style="-keep: true">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; text-align: center; font-weight: bold"><span style="-keep: true">Number of
    <br/>
    Shares of <br/>
    Common Stock<br/>
    Owned Prior to<br/>
    Offering</span></td><td style="white-space: nowrap; text-align: left; font-weight: bold"><span style="-keep: true">&#160;</span></td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"><span style="-keep: true">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="-keep: true">Maximum <br/>
    Number of <br/>
    Shares of <br/>
    Common Stock<br/>
    to be Sold <br/>
    Pursuant to this<br/>
    Prospectus</span></td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"><span style="-keep: true">&#160;</span></td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"><span style="-keep: true">&#160;</span></td>
    <td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="-keep: true">Shares Beneficially<br/>
    Owned After Offering</span></td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center"><span style="-keep: true">&#160;</span></td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center"><span style="-keep: true">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center"><span style="-keep: true">&#160;</span></td><td style="white-space: nowrap; text-align: left"><span style="-keep: true">&#160;</span></td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center"><span style="-keep: true">&#160;</span></td>
    <td colspan="2" style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center"><span style="-keep: true">&#160;</span></td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center"><span style="-keep: true">&#160;</span></td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"><span style="-keep: true">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="-keep: true">Number</span></td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"><span style="-keep: true">&#160;</span></td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"><span style="-keep: true">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"><span style="-keep: true">Percentage</span></td><td style="padding-bottom: 1.5pt; white-space: nowrap; text-align: center; font-weight: bold"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Armistice
    Capital, LLC<sup>(1)</sup></span></td><td style="width: 1%"><span style="-keep: true">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="-keep: true">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-keep: true">3,542,044</span></td><td style="width: 1%; text-align: left"><sup style="-keep: true">(2)</sup></td><td style="width: 1%"><span style="-keep: true">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="-keep: true">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-keep: true">3,542,044</span></td><td style="width: 1%; text-align: left"><span style="-keep: true">&#160;</span></td><td style="width: 1%"><span style="-keep: true">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="-keep: true">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-keep: true">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="-keep: true">&#160;</span></td><td style="width: 1%"><span style="-keep: true">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="-keep: true">&#160;</span></td><td style="width: 9%; text-align: right"><span style="-keep: true">&#8212;</span></td><td style="width: 1%; text-align: left"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">H.C.
    Wainwright &amp; Co., LLC<sup>(3)</sup></span></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="-keep: true">66,127</span></td><td style="text-align: left"><sup style="-keep: true">(4)</sup></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="-keep: true">66,127</span></td><td style="text-align: left"><span style="-keep: true">&#160;</span></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="-keep: true">&#160;</span></td><td style="text-align: left"><span style="-keep: true">&#160;</span></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="-keep: true">&#160;</span></td><td style="text-align: left"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles
    Worthman<sup>(5)</sup></span></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">890
                                            </span></td><td style="text-align: left"><sup style="-keep: true">(6)</sup></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="-keep: true">890</span></td><td style="text-align: left"><span style="-keep: true">&#160;</span></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="-keep: true">&#8212;</span></td><td style="text-align: left"><span style="-keep: true">&#160;</span></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="-keep: true">&#8212;</span></td><td style="text-align: left"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Craig
    Schwabe<sup>(5)</sup></span></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,003
                                            </span></td><td style="text-align: left"><sup style="-keep: true">(7)</sup></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="-keep: true">3,003</span></td><td style="text-align: left"><span style="-keep: true">&#160;</span></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="-keep: true">&#8212;</span></td><td style="text-align: left"><span style="-keep: true">&#160;</span></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="-keep: true">&#8212;</span></td><td style="text-align: left"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael
    Vasinkevich<sup>(5)</sup></span></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">57,060
                                            </span></td><td style="text-align: left"><sup style="-keep: true">(8)</sup></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="-keep: true">57,060</span></td><td style="text-align: left"><span style="-keep: true">&#160;</span></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="-keep: true">&#8212;</span></td><td style="text-align: left"><span style="-keep: true">&#160;</span></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="-keep: true">&#8212;</span></td><td style="text-align: left"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-indent: -10pt; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noam
    Rubinstein<sup>(5)</sup></span></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">28,030
                                            </span></td><td style="text-align: left"><sup style="-keep: true">(9)</sup></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="-keep: true">28,030</span></td><td style="text-align: left"><span style="-keep: true">&#160;</span></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="-keep: true">&#8212;</span></td><td style="text-align: left"><span style="-keep: true">&#160;</span></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">&#160;</span></td><td style="text-align: right"><span style="-keep: true">&#8212;</span></td><td style="text-align: left"><span style="-keep: true">&#160;</span></td></tr>
  </table><div>


</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Rule-Page --><div style="width: 25%"><div style="font-size: 1pt; border-top: Black 1.5pt solid">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>


</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">(1)</span></td><td style="text-align: justify"><span style="-keep: true">The securities are
                                            directly held by Armistice Capital Master Fund Ltd., a Cayman Islands exempted company (the
                                            &#8220;Master Fund&#8221;), and may be deemed to be beneficially owned by: (i)&#160;Armistice
                                            Capital, LLC (&#8220;Armistice Capital&#8221;), as the investment manager of the Master Fund;
                                            and (ii)&#160;Steven Boyd, as the Managing Member of Armistice Capital. The warrants are
                                            subject to a beneficial ownership limitation of 4.99%, which such limitation restricts the
                                            Selling Stockholder from exercising that portion of the warrants that would result in the
                                            Selling Stockholder and its affiliates owning, after exercise, a number of shares of common
                                            stock in excess of the beneficial ownership limitation. The address of Armistice Capital
                                            Master Fund Ltd. is c/o Armistice Capital, LLC, 510 Madison Avenue, 7<sup>th</sup> Floor,
                                            New&#160;York, NY&#160;10022.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></p><div>

</div><!-- Field: Page; Sequence: 13; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">(2)</span></td><td style="text-align: justify"><span style="-keep: true">Consists of (i) 301,000
                                            shares of common stock issued in the December 2023 Private Placement, (ii) 970,187 shares
                                            of common stock issuable upon the exercise of pre-funded warrants in the December 2023 Private
                                            Placement, and (iii) 1,271,187 shares of common stock issuable upon the exercise of warrants
                                            issued in the December 2023 Private Placement, (iv) 944,670 shares of common stock issuable
                                            upon the exercise of warrants issued in the May 2023 Private Placement, and (v) 55,000 shares
                                            of common stock issuable upon the exercise of warrants issued in September 2023. All of these
                                            warrants are subject to a beneficial ownership limitation of 4.99%, which such limitation
                                            restrict the Master Fund from exercising that portion of the warrants that would result in
                                            the Master Fund and its affiliates owning, after exercise, a number of shares of common stock
                                            in excess of the beneficial ownership limitation.</span></td>
</tr></table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">(3)</span></td><td style="text-align: justify"><span style="-keep: true">H.C. Wainwright &amp;
                                            Co., LLC is a registered broker dealer and has a registered address of c/o H.C. Wainwright
                                            &amp; Co., LLC 430 Park Ave, 3rd Floor, New York, NY 10022. H.C. Wainwright &amp; Co., LLC
                                            has sole voting and dispositive power over the securities held. The number of shares beneficially
                                            owned prior to this offering consist of shares of common stock issuable upon exercise of
                                            Placement Agent Warrants, which were received as compensation for the Offering. H.C. Wainwright
                                            &amp; Co., LLC acquired the Placement Agent Warrants in the ordinary course of business and,
                                            at the time the Placement Agent Warrants were acquired, H.C. Wainwright &amp; Co., LLC had
                                            no agreement or understanding, directly or indirectly, with any person to distribute such
                                            securities.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">(4)</span></td><td style="text-align: justify"><span style="-keep: true">Consists of 66,127
                                            shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection
                                            with the May 2023 Private Placement.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p><div>



</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">(5)</span></td><td style="text-align: justify"><span style="-keep: true">Each of the selling
                                            stockholders is affiliated with H.C.&#160;Wainwright&#160;&amp; Co., LLC, a registered broker
                                            dealer with a registered address of H.C.&#160;Wainwright&#160;&amp; Co., LLC, 430 Park Ave,
                                            3<sup>rd</sup> Floor, New&#160;York, NY&#160;10022, and has sole voting and dispositive power
                                            over the securities held. The number of shares beneficially owned prior to this offering
                                            consist of shares of common stock issuable upon exercise of placement agent warrants, which
                                            were received as compensation. The selling stockholder acquired the placement agent warrants
                                            in the ordinary course of business and, at the time the placement agent warrants were acquired,
                                            the selling stockholder had no agreement or understanding, directly or indirectly, with any
                                            person to distribute such securities.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">(6)</span></td><td style="text-align: justify"><span style="-keep: true">Consists of 890 shares
                                            of common stock issuable upon exercise of Placement Agent Warrants issued in connection with
                                            the December 2023 Private Placement.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">(7)</span></td><td style="text-align: justify"><span style="-keep: true">Consists of 3,003
                                            shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection
                                            with the December 2023 Private Placement.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">(8)</span></td><td style="text-align: justify"><span style="-keep: true">Consists of 57,060
                                            shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection
                                            with the December 2023 Private Placement.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">(9)</span></td><td style="text-align: justify"><span style="-keep: true">Consists of 28,030
                                            shares of common stock issuable upon exercise of Placement Agent Warrants issued in connection
                                            with the December 2023 Private Placement.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></p><div>

</div><!-- Field: Page; Sequence: 14; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"><b>&#160;</b></p><div>

</div><div><a id="a_007"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b style="-keep: true">DESCRIPTION OF OFFERED SECURITIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>The following description
is intended as a summary of our Charter and our Bylaws, each of which will become effective prior to the effectiveness of the registration
statement of which this prospectus forms a part, and which will be filed as exhibits to the registration statement of which this prospectus
forms a part, and to the applicable provisions of the DGCL. Because the following is only a summary, it does not contain all of the information
that may be important to you. For a complete description, you should refer to our Charter and Bylaws.</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Authorized Capital Stock</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">Our Charter authorizes
us to issue up to 42,803,774&#160;shares consisting of 30,000,000&#160;shares of common stock with a par value of US$0.0001 per share,
2,803,774&#160;shares of non-voting&#160;common stock with a par value of US$0.0001 per share and 10,000,000&#160;shares of preferred
stock with a par value of US$0.0001 per share. As of March 20, 2024, there were 54 holders of record of our common stock.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Common Stock</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the closing of this offering,
shares of our common stock have the following rights, preferences and privileges:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Voting Rights</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Each holder of common stock
is entitled to one vote for each share of common stock held on all matters submitted to a vote of stockholders. Any action at a meeting
at which a quorum is present will be decided by a majority of the voting power present in person or represented by proxy, except in the
case of any election of directors, which will be decided by a plurality of votes cast. There is no cumulative voting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i style="-keep: true">Dividend Rights</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Holders of our common stock
are entitled to receive dividends when, as and if declared by our board of directors out of funds legally available for payment, subject
to the rights of holders, if any, of any class of stock having preference over the common stock. Any decision to pay dividends on our
common stock will be at the discretion of our board of directors. Our board of directors may or may not determine to declare dividends
in the future. See &#8220;Dividend Policy.&#8221; The board&#8217;s determination to issue dividends will depend upon our profitability
and financial condition any contractual restrictions, restrictions imposed by applicable law and the SEC, and other factors that our board
of directors deems relevant.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Liquidation Rights</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In the event of a voluntary
or involuntary liquidation, dissolution or winding up of the Company, the holders of our common stock will be entitled to share ratably
on the basis of the number of shares held in any of the assets available for distribution after we have paid in full, or provided for
payment of, all of our debts and after the holders of all outstanding series of any class of stock have preference over the common stock,
if any, have received their liquidation preferences in full.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Other Rights and Preferences</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the closing of this offering,
holders of our common stock will have no pre-emptive, conversion, subscription or other rights, and there are no redemption or sinking
fund provisions applicable to our common stock. The rights, preferences and privileges of the holders of our common stock are subject
to and may be adversely affected by the rights of the holders of shares of any series of our preferred stock that we may designate in
the future. Upon the closing of this offering, shares of our common stock are not convertible into shares of any other class of capital
stock, nor are they subject to any redemption or sinking fund provisions.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Fully paid and nonassessable</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">All of our outstanding shares
of common stock are, and the shares of common stock to be issued in this offering will be, fully paid and nonassessable.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 15; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Preferred stock</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">We are authorized to issue
up to 10,000,000&#160;shares of preferred stock. Our Charter authorizes the board to issue these shares in one or more series, to determine
the designations and the powers, preferences and relative, participating, optional or other special rights and the qualifications, limitations
and restrictions thereof, including the dividend rights, conversion or exchange rights, voting rights (including the number of votes per
share), redemption rights and terms, liquidation preferences, sinking fund provisions and the number of shares constituting the series.
Our board of directors could, without stockholder approval, issue preferred stock with voting and other rights that could adversely affect
the voting power and other rights of the holders of common stock and which could have the effect of making it more difficult for a third
party to acquire, or of discouraging a third party from attempting to acquire, a majority of our outstanding voting stock. Upon the closing
of this offering, no shares of preferred stock will be outstanding.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Charter and Bylaw Provisions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><i>Charter and Bylaw Provisions</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Charter and our Bylaws
to be effective upon the closing of this offering, include a number of provisions that could deter hostile takeovers or delay or prevent
changes in control of our management team, including the following:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><i>Board of Directors vacancies. </i>Our
Charter to be effective upon the closing of this offering, provides that vacancies on the board of directors may be filled only by the
affirmative vote of a majority of the directors then in office, irrespective of whether there is a quorum, or by a sole remaining director.
Additionally, the number of directors to serve on our board of directors is fixed solely and exclusively by resolution duly adopted by
our board of directors. This would prevent a stockholder from increasing the size of our board of directors and then gaining control
of our board of directors by filling the resulting vacancies with its own nominees. This makes it more difficult to change the composition
of our board of directors but promotes continuity of management.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><i>Classified Board of Directors. </i>In
accordance with our Charter, as it will be in effect following the effectiveness of the registration statement of which this prospectus
forms a part, our board of directors will be divided into three classes with staggered three-year&#160;terms. At each annual general
meeting of stockholders, the successors to directors whose terms then expire will be elected to serve from the time of election and qualification
until the third annual meeting following election. Our directors will be divided among the three classes. We expect that any additional
directorships resulting from an increase in the number of directors will be distributed among the three classes so that, as nearly as
possible, each class will consist of one-third&#160;of the directors. The division of our board of directors into three classes with
staggered three-year&#160;terms may delay or prevent a change of our management or a change in control.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><i>Special Meetings of Stockholders. </i>Our
Bylaws to be effective upon the closing of this offering, provides that special meetings of our stockholders may be called by the board
of directors acting pursuant to a resolution approved by the affirmative vote of a majority of the directors then in office, and special
meetings of stockholders may not be called by any other person or persons.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><i>No Cumulative Voting. </i>The DGCL
provides that stockholders are not entitled to the right to cumulate votes in the election of directors unless the corporation&#8217;s
certificate of incorporation provides otherwise. Our Charter does not provide for cumulative voting.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><i>Amendment of Charter and Bylaw Provisions. </i>Any
amendment of our Charter requires the affirmative vote of the majority of the outstanding shares of capital stock entitled to vote on
such amendment, and the affirmative vote of the majority of the outstanding shares of each class entitled to vote thereon as a class,
except that the provision in the Charter regarding the staggered board may not be repealed or amended without the vote of the holders
of not less than 80% of the Company&#8217;s voting stock, voting as a single class. Amendments to our Bylaws may be executed pursuant
to a resolution by the Board of Directors pursuant to an affirmative vote of a majority of the directors then in office, or by the affirmative
vote of at least 75% of the outstanding shares of capital stock entitled to vote.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><i>&#160;</i></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 16; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><i>&#160;</i></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><i>&#9679;</i></td><td style="text-align: justify"><i>Delaware Business Combination Statute. </i>The
Company is subject to the &#8220;business combination&#8221; provisions of Section&#160;203 of the DGCL.&#160;In general, Section&#160;203
prohibits a publicly held Delaware corporation from engaging in a business combination with an interested stockholder for a period of
three&#160;years following the date such person becomes an interested stockholder, unless the business</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify">combination or the transaction in which
such person becomes an interested stockholder is approved in a prescribed manner. Generally, a &#8220;business combination&#8221; includes
a merger, asset or stock sale, or other transaction resulting in a financial benefit to the interested stockholder. Generally, an &#8220;interested
stockholder&#8221; is a person that, together with affiliates and associates, owns, or within three&#160;years prior to the determination
of interested stockholder status did own, 15% or more of a corporation&#8217;s voting stock. The existence of this provision may have
an anti-takeover effect with respect to transactions not approved in advance by our Board of Directors, and the anti-takeover effect includes
discouraging attempts that might result in a premium over the market price for the shares of our common stock.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify"><i>Exclusive Forum. </i>Unless we consent
in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware is the sole and exclusive forum for
(i)&#160;any derivative action or proceeding brought on our behalf, (ii)&#160;any action asserting a claim of breach of a fiduciary duty
owed by any of our current or former directors, officers, stockholder or other employees to us or our stockholders, (iii)&#160;any action
asserting a claim against the Corporation or any current or former director, officer, stockholder, employee or agent of the Corporation
arising pursuant to any provision of the DGCL, our Charter or our Bylaws, (iv)&#160;any action to interpret, apply, enforce or determine
the validity of the Company&#8217;s Charter or Bylaws, (v)&#160;any action asserting a claim against us governed by the internal affairs
doctrine or (vi)&#160;any action asserting an &#8220;internal corporate claim&#8221; as that term is defined in Section&#160;115 of the
General Corporation Law. The federal district courts of the United&#160;States of America shall be the exclusive forum for the resolution
of any complaint, claim or proceeding asserting a cause of action arising under the Exchange&#160;Act or the Securities Act. Furthermore,
Section&#160;22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce
any duty or liability created by the Securities Act or the rules and regulations thereunder. Stockholders cannot waive compliance with
the federal securities laws and the rules and regulations thereunder. Any person or entity purchasing or otherwise acquiring or holding
any interest in shares of our capital stock shall be deemed to have notice of and consented to the forum provision in our Charter. This
choice of forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes
with us or our directors, officers or other employees, which may discourage such lawsuits against us and our directors, officers and
other employees.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Anti-Takeover&#160;Provisions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The provisions of the DGCL,
our Charter and our Bylaws may have the effect of delaying, deferring or discouraging another person from acquiring control of our company.
These provisions, which are summarized below, may have the effect of discouraging takeover bids. They are also designed, in part, to encourage
persons seeking to acquire control of us to negotiate first with our board of directors. We believe that the benefits of increased protection
of our potential ability to negotiate with an unfriendly or unsolicited acquirer outweigh the disadvantages of discouraging a proposal
to acquire us because negotiation of these proposals could result in an improvement of their terms.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">Our Charter established
a classified board of directors, divided in three classes with staggered three-year&#160;terms. Under the classified board of directors
structure, only one class of directors would be elected at each annual meeting of our stockholders, with the other classes continuing
for the remainder for their respective three-year&#160;terms. Under the classified board of directors structure: (i)&#160;directors in
Class&#160;I, consisting of Noemi Schmayer, are to stand for election at the Annual Meeting to be held in 2026; (ii)&#160;directors in
Class&#160;II, consisting of Joseph Moscovitz and Naama Halevi-Davidov, are to stand for election at the annual meeting of stockholders
to be held in 2024; and (iii)&#160;directors in Class&#160;III, consisting of Israel Niv and Tuvia Barlev, are to stand for election
at the annual meeting of stockholders to be held in 2025.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Limitations on Liability, Indemnification of
officers and directors and insurance</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Charter and Bylaws contain
provisions that limit the liability of our directors for monetary damages to the fullest extent permitted by the DGCL.&#160;Consequently,
our directors will not be personally liable to us or our stockholders for monetary damages for any breach of fiduciary duties as directors,
except liability for:</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">any breach of the director&#8217;s duty of loyalty to us or
our stockholders;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">any act or omission not in good faith or that involves intentional
misconduct or a knowing violation of law;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">unlawful payments of dividends or unlawful stock repurchases,
or redemptions as provided in Section&#160;174 of the DGCL; or</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">&#9679;</td><td style="text-align: justify">any transaction from which the director derived an improper
personal benefit.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 17; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Listing</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have applied to list our
common stock on the Nasdaq Capital Market under the symbol &#8220;ASNS&#8221;.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Transfer Agent and Registrar</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The transfer agent and registrar
for our common stock will be VStock Transfer, LLC.&#160;The transfer agent and registrar&#8217;s address is 18 Lafayette Place, Woodmere,
NY&#160;11598.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Exclusive Forum</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">Our Charter provides that,
unless we consent in writing to the selection of an alternative forum, the Court of Chancery of the State of Delaware will be the sole
and exclusive forum for any stockholder for (a)&#160;any derivative action or proceeding brought on our behalf, (b)&#160;any action asserting
a claim of breach of a fiduciary duty owed by, or other wrongdoing by, any current or former director, officer, stockholder, employee
or agent of the Company to the Company or the Company&#8217;s stockholders, (c)&#160;any action asserting a claim against the Corporation
or any current or former director, officer, stockholder, employee or agent of the Corporation arising pursuant to any provision of the
DGCL or the Company&#8217;s Certificate of Incorporation or Bylaws, (d)&#160;any action to interpret, apply, enforce or determine the
validity of the Company&#8217;s Certificate of Incorporation or ByIs, or (e)&#160;any action asserting a claim governed by the internal
affairs doctrine or (f)&#160;any action asserting an &#8220;internal corporate claim&#8221; as that term is defined in Section&#160;115
of the General Corporation Law. The federal district courts of the United&#160;States of America shall be the exclusive forum for the
resolution of any complaint, claim or proceeding asserting a cause of action arising under the Exchange&#160;Act or the Securities Act.
Furthermore, Section&#160;22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought
to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Stockholders cannot waive compliance
with the federal securities laws and the rules and regulations thereunder. Any person or entity purchasing or otherwise acquiring or holding
any interest in shares of our capital stock shall be deemed to have notice of and consented to the forum provision in our Charter.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The choice-of-forum&#160;provision
may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with the Company or
its directors, officers or other employees, and may result in increased costs to a stockholder who has to bring a claim in a forum that
is not convenient to the stockholder, which may discourage such lawsuits. Although under Section&#160;115 of the DGCL, exclusive forum
provisions may be included in a company&#8217;s certificate of incorporation, the enforceability of similar forum provisions in other
companies&#8217; certificates or incorporation or bylaws has been challenged in legal proceedings, and it is possible that a court could
find these types of provisions to be inapplicable or unenforceable. If a court were to find the exclusive forum provision of our Charter
inapplicable or unenforceable with respect to one or more of the specified types of actions or proceedings, we may incur additional costs
associated with resolving such matters in other jurisdictions, which could materially and adversely affect our business, financial condition
and results of operations and result in a diversion of the time and resources of our management and board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Anti-Takeover&#160;Provisions of the DGCL and
Charter Provisions</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain provisions of the DGCL
and certain provisions included in our Charter and Bylaws summarized below may be deemed to have an anti-takeover&#160;effect and may
delay, deter, or prevent a tender offer or takeover attempt that a stockholder might consider to be in its best interests, including attempts
that might result in a premium being paid over the market price for the shares held by stockholders.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 18; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Removal of Directors</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Bylaws provide that stockholders
may only remove a director with or without cause by a vote of no less than a majority of the shares present in person or by proxy at the
meeting and entitled to vote, voting together as a single class.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Amendments to Certificate of Incorporation</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Certain sections of our Certificate
of Incorporation require the affirmative vote of the holders of a majority of the voting power of the then outstanding shares of capital
stock of the Company entitled to vote, voting together as a single class, except that the provision in the Charter regarding the staggered
board may not be repealed or amended without the vote of the holders of not less than 80% of the Company&#8217;s voting stock, voting
as a single class.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Staggered Board</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The board of directors is divided
into three classes, with regular three-year&#160;staggered terms. This classification system increases the difficulty of replacing a majority
of the directors and may tend to discourage a third-party&#160;from making a tender offer or otherwise attempting to gain control of the
Company. In addition, under Delaware law, the Certificate and the By-Laws, the Company&#8217;s directors may be removed from office by
the stockholders only for cause and only in the manner provided for in the Certificate. These factors may maintain the incumbency of the
board of directors.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Amendments to Bylaws</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Charter limits the abilities
of the directors and stockholders to amend our Bylaws in certain circumstances. In particular, the Bylaws may be amended only by the vote
of a majority of all of the directors then in office, or by the affirmative vote of the stockholders holding at least 75% of the outstanding
shares of capital stock entitled to vote in accordance with the provisions of the Charter, Bylaws, and the DGCL.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>No Cumulative Voting</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Charter does not provide
for cumulative voting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>&#160;</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><i>Special Meetings of Stockholders</i></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Our Bylaws provide that, except
as otherwise required by law, special meetings of the stockholders may be called only by an officer at the request of a majority of our
board of directors, by our Chief Executive Officer or President or by the holders of not less than 25% of the holders of stock entitled
to vote at the meeting.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Stockholders Agreement</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We are party to the Amended
and Restated Stockholders Agreement, dated February 2, 2016, or the Stockholders Agreement, pursuant to which certain holders of our common
stock have the right to demand that we file a registration statement or request that their common stock be covered by a registration statement
that we are otherwise filing. All rights under the Stockholders Agreement will terminate upon the closing of this offering.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>


</div><!-- Field: Page; Sequence: 19; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><div><a id="a_008"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b style="-keep: true">PLAN OF DISTRIBUTION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">The selling stockholders
of the Shares and any of its pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their securities
covered hereby on the Nasdaq Capital Market or any other stock exchange, market or trading facility on which the securities are traded
or in private transactions. These sales may be at fixed or negotiated prices. The selling stockholders may use any one or more of the
following methods when selling securities:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">ordinary brokerage
                                            transactions and transactions in which the broker-dealer solicits purchasers;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">block trades
                                            in which the broker-dealer will attempt to sell the securities as agent but may position
                                            and resell a portion of the block as principal to facilitate the transaction;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">purchases by
                                            a broker-dealer as principal and resale by the broker-dealer for its account;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">an exchange
                                            distribution in accordance with the rules of the applicable exchange;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">privately negotiated
                                            transactions;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">settlement of
                                            short sales;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">in transactions
                                            through broker-dealers that agree with the selling stockholder to sell a specified number
                                            of such securities at a stipulated price per security;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">through the
                                            writing or settlement of options or other hedging transactions, whether through an options
                                            exchange or otherwise;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">a combination
                                            of any such methods of sale; or</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">any other method
                                            permitted pursuant to applicable law.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">The selling stockholders
may also sell securities under Rule&#160;144 or any other exemption from registration under the Securities Act, if available, rather
than under this prospectus.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">Broker-dealers engaged
by the selling stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or
discounts from each selling stockholder (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser)
in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in
excess of a customary brokerage commission in compliance with FINRA Rule&#160;2121; and in the case of a principal transaction a markup
or markdown in compliance with FINRA Rule&#160;2121.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">In connection with the
sale of the securities or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers or other
financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume.
The selling stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge
the securities to broker-dealers that in turn may sell these securities. The selling stockholders may also enter into option or other
transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the delivery
to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or
other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">The selling stockholders
and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221; within the
meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents
and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the
Securities Act. The selling stockholders have informed the Company that it does not have any written or oral agreement or understanding,
directly or indirectly, with any person to distribute the securities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 20; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">The resale securities
will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition,
in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the
applicable state or an exemption from the registration or qualification requirement is available and is complied with.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">Under applicable rules
and regulations under the Exchange&#160;Act, any person engaged in the distribution of the resale securities may not simultaneously engage
in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation&#160;M, prior
to the commencement of the distribution. In addition, the selling stockholders will be subject to applicable provisions of the Exchange&#160;Act
and the rules and regulations thereunder, including Regulation&#160;M, which may limit the timing of purchases and sales of the common
stock by the selling stockholder or any other person. We will make copies of this prospectus available to the selling stockholders and
have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including
by compliance with Rule&#160;172 under the Securities Act).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b style="-keep: true">&#160;</b></p><div>

</div><div><a id="a_009"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>LEGAL MATTERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The validity of the shares of
the common stock offered by this prospectus will be passed upon for us by Pearl Cohen Zedek Latzer Baratz LLP, New York, NY. Certain legal
matters in connection with this offering relating to U.S. law will be passed upon for us by Greenberg Traurig, LLP, New&#160;York, NY.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_010"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>EXPERTS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">The financial statements
incorporated in this Prospectus by reference to the Annual Report on Form 10-K for the year ended December 31, 2023 have been so included
in reliance on the report (which contains an explanatory paragraph relating to the Company&#8217;s ability to continue as a going concern
as described in Note 1b to the financial statements) of Kesselman &amp; Kesselman, Certified Public Accountants (Isr.), a member firm
of PricewaterhouseCoopers International Limited, an independent registered public accounting firm, given on the authority of said firm
as experts in auditing and accounting.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><div><a id="a_011"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>WHERE YOU CAN FIND MORE INFORMATION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">We have filed a registration
statement on Form&#160;S-1 with the SEC under the Securities Act&#160;with respect to the securities offered in this prospectus. This
prospectus, which is filed as part of a registration statement, does not contain all of the information set forth in the registration
statement, some portions of which have been omitted in accordance with the SEC&#8217;s rules and regulations. Statements made in this
prospectus as to the contents of any contract, agreement or other document referred to in this prospectus are not necessarily complete
and are qualified in their entirety by reference to each such contract, agreement or other document that is filed as an exhibit to the
registration statement.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">You can read our SEC filings,
including the registration statement, over the internet at the SEC&#8217;s website. Upon completion of this offering, we will be subject
to the information reporting requirements of the Exchange&#160;Act, and we will file reports, proxy statements and other information
with the SEC.&#160;The SEC&#8217;s website contains reports, proxy and information statements and other information regarding registrants
that file electronically with the SEC.&#160;The address of that site is <i>http://www.sec.gov</i>.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">We also maintain a website
at <i>www.Actelis.com</i>, at which you may access these materials free of charge as soon as reasonably practicable after they are electronically
filed with, or furnished to, the SEC.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>However, the information
contained in or accessible through our website is not part of this prospectus or the registration statement of which this prospectus forms
a part, and investors should not rely on such information in making a decision to purchase our common stock in this offering.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 21; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b style="-keep: true">PLAN OF DISTRIBUTION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">The selling stockholders
of the Shares and any of its pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their securities
covered hereby on the Nasdaq Capital Market or any other stock exchange, market or trading facility on which the securities are traded
or in private transactions. These sales may be at fixed or negotiated prices. The selling stockholders may use any one or more of the
following methods when selling securities:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">ordinary brokerage
                                            transactions and transactions in which the broker-dealer solicits purchasers;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">block trades
                                            in which the broker-dealer will attempt to sell the securities as agent but may position
                                            and resell a portion of the block as principal to facilitate the transaction;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">purchases by
                                            a broker-dealer as principal and resale by the broker-dealer for its account;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">an exchange
                                            distribution in accordance with the rules of the applicable exchange;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">privately negotiated
                                            transactions;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">settlement of
                                            short sales;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">in transactions
                                            through broker-dealers that agree with the selling stockholder to sell a specified number
                                            of such securities at a stipulated price per security;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">through the
                                            writing or settlement of options or other hedging transactions, whether through an options
                                            exchange or otherwise;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">a combination
                                            of any such methods of sale; or</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">any other method
                                            permitted pursuant to applicable law.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">The selling stockholders
may also sell securities under Rule&#160;144 or any other exemption from registration under the Securities Act, if available, rather
than under this prospectus.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">Broker-dealers engaged
by the selling stockholders may arrange for other brokers-dealers to participate in sales. Broker-dealers may receive commissions or
discounts from each selling stockholder (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser)
in amounts to be negotiated, but, except as set forth in a supplement to this prospectus, in the case of an agency transaction not in
excess of a customary brokerage commission in compliance with FINRA Rule&#160;2121; and in the case of a principal transaction a markup
or markdown in compliance with FINRA Rule&#160;2121.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">In connection with the
sale of the securities or interests therein, the selling stockholders may enter into hedging transactions with broker-dealers or other
financial institutions, which may in turn engage in short sales of the securities in the course of hedging the positions they assume.
The selling stockholders may also sell securities short and deliver these securities to close out their short positions, or loan or pledge
the securities to broker-dealers that in turn may sell these securities. The selling stockholders may also enter into option or other
transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the delivery
to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer or
other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">The selling stockholders
and any broker-dealers or agents that are involved in selling the securities may be deemed to be &#8220;underwriters&#8221; within the
meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents
and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts under the
Securities Act. The selling stockholders have informed the Company that it does not have any written or oral agreement or understanding,
directly or indirectly, with any person to distribute the securities.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">The resale securities
will be sold only through registered or licensed brokers or dealers if required under applicable state securities laws. In addition,
in certain states, the resale securities covered hereby may not be sold unless they have been registered or qualified for sale in the
applicable state or an exemption from the registration or qualification requirement is available and is complied with.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">Under applicable rules
and regulations under the Exchange&#160;Act, any person engaged in the distribution of the resale securities may not simultaneously engage
in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation&#160;M, prior
to the commencement of the distribution. In addition, the selling stockholders will be subject to applicable provisions of the Exchange&#160;Act
and the rules and regulations thereunder, including Regulation&#160;M, which may limit the timing of purchases and sales of the common
stock by the selling stockholder or any other person. We will make copies of this prospectus available to the selling stockholders and
have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including
by compliance with Rule&#160;172 under the Securities Act).</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><!-- Field: Page; Sequence: 22; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><b>&#160;</b></p><div>

</div><div><a id="a_012"></a></div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b style="-keep: true">INCORPORATION OF CERTAIN INFORMATION BY
REFERENCE</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b style="-keep: true">&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">The SEC allows us to &#8220;incorporate
by reference&#8221; information into this prospectus. This means that we can disclose important information to you by referring you to
another document filed separately with the SEC. The information that we incorporate by reference is considered to be part of this prospectus.
Because we are incorporating by reference our future filings with the SEC, this prospectus is continually updated and those future filings
may modify or supersede some or all of the information included or incorporated in this prospectus. This means that you must look at
all of the SEC filings that we incorporate by reference to determine if any of the statements in this prospectus or in any document previously
incorporated by reference have been modified or superseded.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="-keep: true">This prospectus incorporates by reference the
documents listed below that have been previously filed with the SEC:</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">our Annual Report
                                            on <a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1141284/000121390024026069/ea0202031-10k_actelis.htm">Form 10-K</a> for the fiscal year ended December 31, 2023, filed with the SEC on March 26,
                                            2024;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">our Current
                                            Reports on Form 8-K filed with the SEC on <a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024001929/ea191185-8k_actelis.htm">January
                                            8, 2024</a>, <a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024012307/ea193444-8k_actelis.htm">February
                                            12, 2024</a>, <a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024014088/ea193785-8k_actelis.htm">February
                                            14, 2024</a> and <a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024022669/ea0201793-8k_actelis.htm">March
                                            14, 2024;</a></span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="-keep: true">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">&#9679;</span></td><td style="text-align: justify"><span style="-keep: true">the description
                                            of our common stock, which is contained in the registration statement on <a href="https://www.sec.gov/Archives/edgar/data/1141284/000121390022023871/ea159353-8a12b_actelis.htm">Form 8-A</a> filed with the SEC on May 4, 2022 (File No. 001-41375).</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="-keep: true">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">We also incorporate by
reference all future documents (excluding information furnished pursuant to Items 2.02 and 7.01 of Form 8-K) we file with the SEC pursuant
to Sections 13(a), 13(c), 14 or 15(d) of the Securities Exchange Act, subsequent to the date of this prospectus and prior to the termination
of the offering.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="-keep: true">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">You should rely only on
the information incorporated by reference or provided in this prospectus. We have not authorized anyone else to provide you with different
information. Any statement contained in a document incorporated by reference into this prospectus will be deemed to be modified or superseded
for the purposes of this prospectus to the extent that a later statement contained in this prospectus or in any other document incorporated
by reference into this prospectus modifies or supersedes the earlier statement. Any statement so modified or superseded will not be deemed,
except as so modified or superseded, to constitute a part of this prospectus. You should not assume that the information in this prospectus
is accurate as of any date other than the date of this prospectus or the date of the documents incorporated by reference in this prospectus.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">The information about us contained
in this prospectus should be read together with the information in the documents incorporated by reference. You may request a copy of
any or all of these filings, at no cost, by writing or telephoning us at Yoav Efron, Chief Financial Officer, 4039 Clipper Court, Fremont,
CA 94538 , Israel, telephone number 908-242-6463 or by emailing us at yoave@actelis.com.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>


</div><!-- Field: Page; Sequence: 23; Options: NewSection; Value: 18 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><img alt="" src="image_001.jpg"/></b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>Actelis Networks, Inc.</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>

</div><!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PRELIMINARY PROSPECTUS</b></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 3pt; margin-bottom: 3pt; width: 100%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></p><div>



</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0.25in"><b>  ,
2024</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Through and including 2024 (the 25<sup>th</sup>
day after the date of this offering), all dealers effecting transactions in these securities, whether or not participating in this offering,
may be required to deliver a prospectus. This is in addition to a dealer&#8217;s obligation to deliver a prospectus when acting as an
underwriter and with respect to an unsold allotment or subscription.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><div>


</div><!-- Field: Page; Sequence: 24 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="margin: 0pt"></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>PART&#160;II</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>INFORMATION NOT REQUIRED IN PROSPECTUS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM&#160;13. OTHER
EXPENSES OF ISSUANCE AND DISTRIBUTION</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following table sets forth
the costs and expenses payable by the Company in connection with this offering. All expenses incurred with respect to the registration
of the common stock will be borne by the Company. All amounts are estimates, except the SEC registration fee.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 88%; text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="-keep: true">SEC registration fee</span></td><td style="width: 1%"><span style="-keep: true">&#160;</span></td>
    <td style="width: 1%; text-align: left"><span style="-keep: true">$</span></td><td style="width: 9%; text-align: right"><span style="-keep: true">570.26</span></td><td style="width: 1%; text-align: left"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="-keep: true">Printing expenses</span></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">$</span></td><td style="text-align: right"><span style="-keep: true">5,000</span></td><td style="text-align: left"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left; text-indent: -10pt; padding-left: 10pt"><span style="-keep: true">Accounting fees and expenses</span></td><td><span style="-keep: true">&#160;</span></td>
    <td style="text-align: left"><span style="-keep: true">$</span></td><td style="text-align: right"><span style="-keep: true">12,000</span></td><td style="text-align: left"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; ">
    <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt"><span style="-keep: true">Legal fees and expenses</span></td><td style="padding-bottom: 1.5pt"><span style="-keep: true">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: left"><span style="-keep: true">$</span></td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-keep: true">50,000</span></td><td style="padding-bottom: 1.5pt; text-align: left"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; padding-bottom: 4pt; text-indent: -10pt; padding-left: 20pt"><span style="-keep: true">Total</span></td><td style="padding-bottom: 4pt"><span style="-keep: true">&#160;</span></td>
    <td style="border-bottom: Black 4pt double; text-align: left"><span style="-keep: true">$</span></td><td style="border-bottom: Black 4pt double; text-align: right"><span style="-keep: true">67,570.26</span></td><td style="padding-bottom: 4pt; text-align: left"><span style="-keep: true">&#160;</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM&#160;14. INDEMNIFICATION
OF DIRECTORS AND OFFICERS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section&#160;102(b)(7)&#160;of
the Delaware General Corporation Law (the &#8220;Delaware Law&#8221;) enables a corporation, in its original certificate of incorporation
or an amendment thereto, to eliminate or limit the personal liability of a director for monetary damages for breach of the director&#8217;s
fiduciary duty, except (i)&#160;for any breach of the director&#8217;s duty of loyalty to the corporation or its stockholders, (ii)&#160;for
acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii)&#160;pursuant to Section&#160;174
of the Delaware Law (providing for liability of directors for unlawful payment of dividends or unlawful stock purchases or redemptions),
or (iv)&#160;for any transaction from which the director derived an improper personal benefit. The Company&#8217;s Sixth Amended and Restated
Certificate of Incorporation, as amended (&#8220;Certificate of Incorporation&#8221;), contains such a provision.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In addition, Section&#160;145
of the Delaware Law provides that a corporation may indemnify any persons, including officers and directors, who are, or are threatened
to be made, party to any threatened, pending or completed legal action, suit or proceeding, whether civil, criminal, administrative or
investigative (other than an action by or in the right of the corporation), by reason of the fact that such person is or was an officer,
director, employee or agent of the corporation, or is or was serving at the request of such corporation as a director, officer, employee
or agent of another corporation or enterprise. The indemnity may include expenses (including attorneys&#8217; fees), judgments, fines
and amounts paid in settlement actually and reasonably incurred by such person in connection with such action, suit or proceeding, provided
such officer, director, employee or agent acted in good faith and in a manner the person reasonably believed to be in or not opposed to
the corporation&#8217;s best interests and, with respect to criminal proceedings, had no reasonable cause to believe that the person&#8217;s
conduct was unlawful. A Delaware corporation may indemnify officers or directors in an action by or in the right of the corporation under
the same conditions, except that no indemnification is permitted without judicial approval if the officer or director is adjudged to be
liable to the corporation. Where an officer or director is successful on the merits or otherwise in the defense of any action referred
to above, the corporation must indemnify him or her against expenses (including attorneys&#8217; fees) that he or she actually and reasonably
incurred.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company&#8217;s Certificate
of Incorporation and Restated Bylaws provide for indemnification of directors and officers to the fullest extent permitted by the Delaware
Law.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 25; Options: NewSection; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM 15. RECENT SALES
OF UNREGISTERED SECURITIES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The following information represents
securities sold by the Company within the past three years which were not registered under the Securities Act.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On December&#160;17, 2023, we
entered into a securities purchase agreement with an Investor,&#160;pursuant to which we agreed to issue and sell to the Investor in a
private placement (i)&#160;301,000 shares of our common stock, (ii) 970,187 pre-funded warrants to purchase up to 970,187 shares of our
common stock and (iii) 1,271,187 shares of common stock issuable upon the exercise of common warrants, at a purchase price of $1.18 per
share of common stock and related common warrant, or $1.1799 per pre-funded warrant and related common warrant, for a total aggregate
gross proceeds of approximately $1.5 million.&#160; The offering closed on December&#160;20, 2023. The common warrants have an exercise
price of $1.18 per share, are exercisable immediately upon issuance and expire five and one-half years following the issuance. The pre-funded
warrants were sold in lieu of shares of common stock, are exercisable immediately upon issuance, have an exercise price of $0.0001 per
share and expire when exercised in full. The Company also agreed to issue to H.C. Wainwright &amp; Co., LLC, the Placement Agent, 88,983
shares of common stock at an exercise price per share of $1.475 and a term of five and one-half years.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif"> </span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif">On
May 4, 2023, we entered into a securities purchase agreement with an Investor, pursuant to which we agreed to issue and sell to the Investor
in a private placement (i) 190,000 shares of our common stock, (ii) 754,670 pre-funded warrants to purchase up to 754,670 shares of our
common stock and (iii) 944,670 </span>shares of common stock issuable upon the exercise of common warrants, at a <span style="font-family: Times New Roman, Times, Serif">purchase
price of $3.705 per share of common stock and related common warrant, or $3.7049 per pre-funded warrant and related common warrant, for
a total aggregate gross proceeds of approximately $3.5 million. The Offering closed on May 8, 2023. Following an amendment in September
2023, the common warrants now have an exercise price of $2.75 per share, are exercisable immediately upon issuance and expire five and
one-half years following the issuance. The pre-funded warrants were sold in lieu of shares of common stock, are exercisable immediately
upon issuance, have an exercise price of $0.0001 per share and expire when exercised in full. The Company also agreed to issue to H.C.
Wainwright &amp; Co., LLC, the Placement Agent, 66,127 shares of common stock at an exercise price per share of $4.6313 and a term of
five and one-half years.</span></span><span style="font-family: Times New Roman, Times, Serif"> </span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.5in">On November 8, 2023, we issued
to H.C. Wainwright &amp; Co., LLC an additional 55,000 shares of common stock issuable upon the exercise of common warrants, at a purchase
price of $ $2.75 per share. As part of the December 2023 Private Placement, we agreed, subject to our shareholders approval, which has
not yet been obtained, to amend the exercise price of the warrants to $1.18 per share.</p><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">The securities above were
offered and sold pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act since, among
other things, the transactions did not involve a public offering.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>


</div><!-- Field: Page; Sequence: 26; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b style="-keep: true">ITEM&#160;16. EXHIBITS AND FINANCIAL STATEMENT
SCHEDULES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>(a) Exhibits.</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="border-bottom: Black 1.5pt solid; padding-bottom: 1.5pt; width: 9%; padding-right: 3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit&#160;No.</b></span></td>
    <td style="padding-bottom: 1.5pt; white-space: nowrap; width: 1%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 90%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.1</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022025173/fs12022a4ex3-5_actelisnet.htm">Form of the Twenty-Fourth Amended and Restated Certificate of Incorporation of the Registrant, dated May 2, 2022 (as filed as Exhibit 3.5 to the Company&#8217;s Form S-1/A, filed on May 10, 2022)</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.2</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022023064/fs12022a1ex3-4_actelisnet.htm">Amended and Restated Bylaws of Actelis Networks, Inc. (as filed as Exhibit 3.4 to the Company&#8217;s Form S-1/A, filed on May 10, 2022)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.1</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023024106/f10k2022ex4-1_actelisnet.htm">Description of Securities (filed as Exhibit 4.1 to the Company&#8217;s Form&#160;10-K for the fiscal year ended December&#160;31, 2022, filed on March&#160;29, 2023)</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.2</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022023064/fs12022a1ex4-1_actelisnet.htm">Form of Representative&#8217;s Warrant (as filed as Exhibit 4.1 to the Company&#8217;s Form&#160;S-1/A, filed on May&#160;2, 2022)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.3</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023037340/ea178132ex4-1_actelis.htm">Form of Common Warrant (as filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form&#160;8-K, filed on May&#160;8, 2023)</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.4</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023037340/ea178132ex4-2_actelis.htm">Form of Pre-Funded Warrant (as filed as Exhibit 4.2 to the Company&#8217;s Current Report on Form&#160;8-K, filed on May&#160;8, 2023)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.5</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023037340/ea178132ex4-3_actelis.htm">Form of Placement Agent Warrant (as filed as Exhibit 4.3 to the Company&#8217;s Current Report on Form&#160;8-K, filed on May&#160;8, 2023)</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.6</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023097390/ea190433ex4-1_actelis.htm">Form of Common Warrant (as filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form&#160;8-K, filed on December&#160;20, 2023)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.7</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023097390/ea190433ex4-2_actelis.htm">Form of Pre-Funded Warrant (as filed as Exhibit 4.2 to the Company&#8217;s Current Report on Form&#160;8-K, filed on December&#160;20, 2023)</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.8</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023097390/ea190433ex4-3_actelis.htm">Form
    of Placement Agent Warrant (as filed as Exhibit 4.3 to the Company&#8217;s Current Report on Form&#160;8-K, filed on December&#160;20,
    2023)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.9</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390024014088/ea193785ex4-1_actelis.htm">Form
    of Credit Agreement (as filed as Exhibit 4.1 to the Company&#8217;s Current Report on Form 8-K, as filed on February 14, 2024).</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5.1*</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt"><a href="ea020247501ex5-1_actelis.htm">Opinion of Pearl Cohen Latzer Zedek Baratz LLP</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.1</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022023064/fs12022a1ex10-2_actelisnet.htm">Lease by and between Actelis Networks Israel, Ltd. and Moshe Smucha, dated January&#160;13, 2000 (as&#160;filed as Exhibit 10.2 to the Company&#8217;s Form&#160;S-1/A, filed on May&#160;2, 2022)</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.2</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022023064/fs12022a1ex10-3_actelisnet.htm">First Amendment to the Lease and Management Agreements from October&#160;22, 2017, by and between Homerton Investments, Ltd. and Actelis Networks Israel Ltd., dated April&#160;14, 2021 (as filed as Exhibit 10.3 to the Company&#8217;s Form&#160;S-1/A, filed on May&#160;2, 2022)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.3</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022020064/fs12022ex10-9_actelisnet.htm">Employment Agreement between Actelis Networks, Inc. and Mr.&#160;Tuvia Barlev dated February&#160;15, 2015 (as filed as Exhibit 10.9 to the Company&#8217;s Form&#160;S-1/A, filed on May&#160;2, 2022)</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.4</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022020064/fs12022ex10-10_actelisnet.htm">Offer letter between Actelis Networks, Inc. and Mr.&#160;Yoav Efron dated November&#160;30, 2017 (as furnished as Exhibit 10.10 to the Company&#8217;s Form&#160;S-1/A, filed on May&#160;10, 2022)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.5</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022023064/fs12022a1ex10-11_actelisnet.htm">Employment Agreement between Actelis Networks Israel, Ltd. And Mr.&#160;Yoav Efron dated November&#160;30, 2017 (as furnished as Exhibit 10.11 to the Company&#8217;s Form&#160;S-1/A, filed on May&#160;10, 2022)</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.6</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022020064/fs12022ex10-12_actelisnet.htm">Consulting Agreement between Actelis Networks, Inc. and Barlev Enterprises dated February&#160;20, 2015 (as furnished as Exhibit 10.12 to the Company&#8217;s Form&#160;S-1/A, filed on May&#160;10, 2022)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.7</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022020064/fs12022ex10-13_actelisnet.htm">Actelis Networks, Inc. 2015 Equity Incentive Plan (as filed as Exhibit 10.13 to the Company&#8217;s Form&#160;S-1, filed on April&#160;15, 2022)</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.8</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022020064/fs12022ex10-14_actelisnet.htm">Amendment No. 1 to 2015 Equity Incentive Plan (as filed as Exhibit 10.14 to the Company&#8217;s Form&#160;S-1, filed on April&#160;15, 2022)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.9</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022020064/fs12022ex10-16_actelisnet.htm">Senior Loan Agreement between Migdalor Business Investment Fund and Actelis Networks Israel, Ltd., dated December&#160;2, 2020 (as filed as Exhibit 10.16 to the Company&#8217;s Form&#160;S-1, filed on April&#160;15, 2022)</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.10</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022020064/fs12022ex10-17_actelisnet.htm">Amendment Number 1 to Senior Loan Agreement between Migdalor Business Investment Fund and Actelis Networks Israel, Ltd., dated November&#160;17, 2021 (as filed as Exhibit 10.17 to the Company&#8217;s Form&#160;S-1, filed on April&#160;15, 2022)</a></span></td></tr>
</table><div>

</div><p style="margin: 0">&#160;</p><div>

</div><p style="margin: 0"></p><div>

</div><!-- Field: Page; Sequence: 27; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="margin: 0">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.11</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt; width: 1%">&#160;</td>
    <td style="text-align: justify; width: 90%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022020064/fs12022ex10-18_actelisnet.htm">Securities Purchase and Loan Repayment Agreement between Actelis Networks, Inc. and Mr.&#160;Tuvia Barlev dated April&#160;15, 2022 (as filed as Exhibit 10.18 to the Company&#8217;s Form&#160;S-1, filed on April&#160;15, 2022)</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.12</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023037340/ea178132ex10-1_actelis.htm">Form of Securities Purchase Agreement (as filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form&#160;8-K, filed on May&#160;8, 2023)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.13</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023037340/ea178132ex10-2_actelis.htm">Form of Registration Rights Agreement (as filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form&#160;8-K, filed on May&#160;8, 2023)</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.14</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="https://www.sec.gov/Archives/edgar/data/1141284/000121390023097390/ea190433ex10-2_actelis.htm">Form of Warrant Amendment (as filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K, filed on December 20, 2023)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.15</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023097390/ea190433ex10-1_actelis.htm">Form of Securities Purchase Agreement (as filed as Exhibit 10.1 to the Company&#8217;s Current Report on Form 8-K, filed on December 20, 2023)</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.16</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023097390/ea190433ex10-2_actelis.htm">Form of Warrant Amendment (as filed as Exhibit 10.2 to the Company&#8217;s Current Report on Form 8-K, filed on December 20, 2023)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10.17</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390023097390/ea190433ex10-3_actelis.htm">Form of Registration Rights Agreement (as filed as Exhibit 10.3 to the Company&#8217;s Current Report on Form 8-K, filed on December 20, 2023)</a></span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">21.1</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="http://www.sec.gov/Archives/edgar/data/1141284/000121390022020064/fs12022ex21-1_actelisnet.htm">Subsidiaries of the Registrant (as filed as Exhibit 21.1 to the Company&#8217;s Form S-1, filed on April 15, 2022)</a></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">23.1*</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: justify"><a href="ea020247501ex23-1_actelis.htm"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consent
    of Kesselman &amp; Kesselman, Certified Public Accountants (Isr.) a member firm of PricewaterhouseCoopers International Limited,
    independent registered accounting firm for the Company</span></a></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.INS</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Instance Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.SCH</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Schema Document.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.CAL</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Calculation Linkbase Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.DEF</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Definition Linkbase Document.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.LAB</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Label Linkbase Document.</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">101.PRE</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inline XBRL Taxonomy Extension Presentation Linkbase Document.</span></td></tr>
  <tr style="vertical-align: top; ">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">104</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt">&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">107*</span></td>
    <td style="white-space: nowrap; padding-bottom: 2.25pt"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="ea020247501ex-fee_actelis.htm">Filing Fee Table</a></span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Filed herewith</td>
</tr></table><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="-keep: true">**</span></td><td style="text-align: justify"><span style="-keep: true">Previously filed.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">(b) Financial
Statement Schedules</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 24pt; text-align: justify; text-indent: -24pt"><span style="-keep: true">&#160;</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true">All financial statement
schedules are omitted because the information required to be set forth therein is not applicable or is included in the consolidated financial
statements or related notes incorporated herein by reference.</span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 28; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>ITEM&#160;17. UNDERTAKINGS</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">(a)</td><td style="text-align: justify">The undersigned registrant hereby undertakes:</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">To file, during any period in which offers or sales are being
made, a post-effective amendment to this registration statement:</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">(i)</span></td><td style="text-align: justify"><span style="-keep: true">To include any prospectus
                                            required by section 10(a)(3)&#160;of the Securities Act;</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left">(ii)</td><td style="text-align: justify">To reflect in the prospectus any facts or events arising after
the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the
aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing,
any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which
was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus
filed with the Commission pursuant to Rule&#160;424(b)&#160;if, in the aggregate, the changes in volume and price represent no more than
20% change in the maximum aggregate offering price set forth in the &#8220;Calculation of Registration Fee&#8221; table in the effective
registration statement.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">(iii)</span></td><td style="text-align: justify"><span style="-keep: true">To include any material
                                            information with respect to the plan of distribution not previously disclosed in the registration
                                            statement or any material change to such information in the registration statement;&#160;<i>provided</i>,&#160;<i>however</i>,
                                            that paragraphs (a)(1)(i), (a)(1)(ii), and (a)(1)(iii)&#160;of this section do not apply
                                            if the information required to be included in a post-effective amendment by those paragraphs
                                            is contained in reports filed with or furnished to the SEC by the registrant pursuant to
                                            section 13 or section 15(d)&#160;of the Exchange&#160;Act&#160;that are incorporated by reference
                                            in the registration statement.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">(2)</span></td><td style="text-align: justify"><span style="-keep: true">That, for the purpose
                                            of determining any liability under the Securities Act, each such post-effective amendment
                                            shall be deemed to be a new registration statement relating to the securities offered therein,
                                            and the offering of such securities at that time shall be deemed to be the initial bona fide
                                            offering thereof.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">To remove from registration by means of a post-effective
amendment any of the securities being registered which remain unsold at the termination of the offering.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt"></p><div>

</div><!-- Field: Page; Sequence: 29; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">(4)</span></td><td style="text-align: justify"><span style="-keep: true">That, for the purpose
                                            of determining liability under the Securities Act to any purchaser, each prospectus filed
                                            pursuant to Rule&#160;424(b)&#160;as part of a registration statement relating to an offering,
                                            other than registration statements relying on Rule&#160;430B or other than prospectuses filed
                                            in reliance on Rule&#160;430A, shall be deemed to be part of and included in the registration
                                            statement as of the date it is first used after effectiveness. Provided, however, that no
                                            statement made in a registration statement or prospectus that is part of the registration
                                            statement or made in a document incorporated or deemed incorporated by reference into the
                                            registration statement or prospectus that is part of the registration statement will, as
                                            to a purchaser with a time of contract of sale prior to such first use, supersede or modify
                                            any statement that was made in the registration statement or prospectus that was part of
                                            the registration statement or made in any such document immediately prior to such date of
                                            first use.</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left"><span style="-keep: true">(5)</span></td><td style="text-align: justify"><span style="-keep: true">That, for the purpose
                                            of determining liability of the registrant under the Securities Act to any purchaser in the
                                            initial distribution of the securities, the undersigned registrant undertakes that in a primary
                                            offering of securities of the undersigned registrant pursuant to this registration statement,
                                            regardless of the underwriting method used to sell the securities to the purchaser, if the
                                            securities are offered or sold to such purchaser by means of any of the following communications,
                                            the undersigned registrant will be a seller to the purchaser and will be considered to offer
                                            or sell such securities to such purchaser:</span></td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left">(i)</td><td style="text-align: justify">Any preliminary prospectus or prospectus of the undersigned
registrant relating to the offering required to be filed pursuant to Rule&#160;424;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left">(ii)</td><td style="text-align: justify">Any free writing prospectus relating to the offering prepared
by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left">(iii)</td><td style="text-align: justify">The portion of any other free writing prospectus relating to
the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned
registrant; and</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 96pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 1in"/><td style="width: 0.25in; text-align: left">(iv)</td><td style="text-align: justify">Any other communication that is an offer in the offering made
by the undersigned registrant to the purchaser.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">(b)</td><td style="text-align: justify">That, insofar as indemnification for liabilities arising under
the Securities Act may be permitted to directors, officers and controlling persons of the registrant pursuant to the foregoing provisions,
or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed
in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other
than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the
successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with
the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling
precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as
expressed in the Securities Act and will be governed by the final adjudication of such issue.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 48pt; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.5in"/><td style="width: 0.25in; text-align: left">(c)</td><td style="text-align: justify">The undersigned registrant hereby undertakes:</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">That, for the purpose of determining any liability under
the Securities Act, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement
relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide
offering thereof.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.75in"/><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">That, for purposes of determining any liability under the Securities
Act, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule&#160;430A
and contained in a form of prospectus filed by the registrant pursuant to Rule&#160;424(b)(1)&#160;or (4)&#160;or 497(h)&#160;under the
Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.</td>
</tr></table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -24pt">&#160;</p><div>


</div><!-- Field: Page; Sequence: 30; Value: 1 --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div><div>
    </div><div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;<b>&#160;</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="-keep: true"><span style="font-family: Times New Roman, Times, Serif">Pursuant
to the requirements of the Securities Act&#160;of&#160;1933, the registrant has duly caused this registration statement on Form S-1/A
to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Freemont, California on </span>March 26, 2024<span style="font-family: Times New Roman, Times, Serif">.</span></span></p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ACTELIS NETWORKS, INC.</b></span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2" style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">&#160;</td>
    <td style="width: 4%; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Tuvia Barlev</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tuvia Barlev</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer and Secretary</span></td></tr>
  </table><div>
</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements
of the Securities Act of 1933, this amendment to the registration statement on Form S-1/A has been signed by the following persons in
the capacities and on the dates indicated.</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center; border-bottom: black 1.5pt solid; width: 33%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Signature</b></span></td>
    <td style="white-space: nowrap; width: 1%"><span style="-keep: true">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 45%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Title</b></span></td>
    <td style="white-space: nowrap; width: 1%"><span style="-keep: true">&#160;</span></td>
    <td style="border-bottom: black 1.5pt solid; width: 20%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Tuvia Barlev</i></span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Executive Officer
    and Chairman of the Board of Directors</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 26, 2024</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tuvia Barlev</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Executive
    Officer)</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="-keep: true">&#160;</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: justify"><span style="-keep: true">&#160;</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chief Financial Officer</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 26, 2024</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Yoav Efron</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Principal Financial
    Officer and Principal Accounting Officer)</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="-keep: true">&#160;</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: justify"><span style="-keep: true">&#160;</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 26, 2024</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joseph Moscovitz</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="-keep: true">&#160;</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 26, 2024</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dr.&#160;Naama Halevi-Davidov</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="-keep: true">&#160;</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 26, 2024</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Israel Niv</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="-keep: true">&#160;</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="-keep: true">&#160;</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1.5pt solid"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">*</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Director</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 26, 2024</span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noemi Schmayer</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td><span style="-keep: true">&#160;</span></td>
    <td style="white-space: nowrap"><span style="-keep: true">&#160;</span></td>
    <td style="text-align: center"><span style="-keep: true">&#160;</span></td></tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: justify; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1.5pt solid; text-align: justify; width: 36%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/
    Tuvia Barlev</span></td>
    <td style="width: 60%"><span style="-keep: true">&#160;</span></td>
    </tr>
  <tr style="vertical-align: bottom">
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="-keep: true">&#160;</span></p></td>
    <td><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="-keep: true">Tuvia Barlev</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="-keep: true">Attorney-in-fact*&#160;</span></p></td>
    <td><span style="-keep: true">&#160;</span></td>
    </tr>
  </table><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>

</div><!-- Field: Page; Sequence: 31; Options: Last --><div>
    </div><div style="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">II-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div><div>
    </div><!-- Field: /Page --><div>

</div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p><div>





</div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" id="hidden-fact-0" name="dei:DocumentType">S-1/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:AmendmentFlag" id="ixv-3456">true</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-3457">0001141284</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="asns-20230930.xsd" xlink:type="simple"/></ix:references>
<ix:resources><xbrli:context id="c0">
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrb8xOYtPeNESS0HWLdfr4iJuQUueersOTwI6y96qaPrzmCkI4XgUC/a77N1YAxjVvK6XJ/t3hMDB6r+bNGOZqdHfzyw7PpxQn2Km5H0n39AcyyD6Cfnt4QpyAwhFAmb33CAAMoNCVuONQx+2VV0p80O5MIBLHJN0mSxLkVBljD+J0FKBIm66YsrwomSAbH7ehCPDMPtd1PEHb+qEqubDMgjSov0ejRX5ak=] CSR-->
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0001141284</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2023-01-01</xbrli:startDate>
    <xbrli:endDate>2023-09-30</xbrli:endDate>
  </xbrli:period>
</xbrli:context></ix:resources></ix:header>

</div></div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>2
<FILENAME>ea020247501ex5-1_actelis.htm
<DESCRIPTION>OPINION OF PEARL COHEN LATZER ZEDEK BARATZ LLP
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; margin: 0"><B>Exhibit 5.1</B></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">March 26, 2024</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Actelis Networks,&nbsp;Inc.<BR>
4039 Clipper Court</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Fremont, CA 94583</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Re: Registration Statement on Form S-1/A</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">Ladies and Gentlemen:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 47.05pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We have acted as counsel to
Actelis Networks, Inc., a Delaware corporation (the &ldquo;<B>Company</B>&rdquo;), in connection with the Registration Statement on Form
S-1/A filed by the Company under the Securities Act of 1933, as amended (the &ldquo;<B>Securities Act</B>&rdquo;), with the United States
Securities and Exchange Commission (the &ldquo;<B>Commission</B>&rdquo;) on the date hereof (the &ldquo;<B>Registration Statement</B>&rdquo;).
The Registration Statement relates to the offering and sale from time to time of up to 3,697,154 shares of the Company&rsquo;s common
stock, $0.0001 par value per share (&ldquo;<B>Common Stock</B>&rdquo;), by the selling stockholders identified in the Registration Statement
(the &ldquo;<B>Selling Stockholders</B>&rdquo;) consisting of (i) 301,000 shares of Common Stock (the &ldquo;<B>December 2023 Shares</B>&rdquo;)
issued in a private placement in December 2023 (the &ldquo;<B>December 2023 Private Placement</B>&rdquo;), (ii) 1,271,187 shares of Common
Stock issuable upon the exercise of warrants (&ldquo;<B>December 2023 Warrants</B>&rdquo;) issued in the December 2023 Private Placement
(the &ldquo;<B>December 2023 Warrant Shares</B>&rdquo;), (iii) 970,187 shares of Common Stock issuable upon the exercise of pre-funded warrants
(&ldquo;<B>December 2023 Pre-Funded Warrants</B>&rdquo;) issued in the December 2023 Private Placement (the &ldquo;<B>December 2023 Pre-Funded
Warrant Shares</B>&rdquo;), (iv) 55,000 shares of Common Stock issuable upon the exercise of warrants (&ldquo;<B>September 2023 Warrants</B>&rdquo;)
issued in September 2023 (the &ldquo;<B>September 2023 Warrant Shares</B>&rdquo;), (v) 944,670 shares of Common Stock (&ldquo;<B>May 2023
Warrant Shares</B>&rdquo;) issuable upon the exercise of warrants (&ldquo;<B>May 2023 Warrants</B>&rdquo;) issued in a private placement
in May 2023 (the &ldquo;<B>May 2023 Private Placement</B>&rdquo;), (vi) 88,983 shares of Common Stock issuable upon the exercise of placement
agent warrants (&ldquo;<B>December 2023 PA Warrants</B>&rdquo;) issued in connection with the December 2023 Private Placement (the &ldquo;<B>December
2023 PA Warrant Shares</B>&rdquo;, and (vii) 66,127 shares of Common Stock issuable upon the exercise of placement agent warrants (the
&ldquo;<B>May 2023 PA Warrants</B>&rdquo;, and together with the May 2023 Warrants, September 2023 Warrants, December 2023 Pre-Funded Warrants,
December PA Warrants and December 2023 Warrants, the &ldquo;<B>Warrants</B>&rdquo;) issued in connection with the May 2023 Private Placement
(the &ldquo;<B>May 2023 PA Shares</B>&rdquo;, and together with the December 2023 PA Warrant Shares, September 2023 Warrant Shares, December
2023 Pre-Funded Warrant Shares, the May 2023 Warrant Shares, and December 2023 Warrant Shares, the &ldquo;<B>Warrant Shares</B>&rdquo;)
and together with the December 2023 Shares, the &ldquo;<B>Shares&rdquo;</B>, and together with the Warrant Shares, the &ldquo;<B>Securities</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with this opinion,
we have examined and relied upon the Registration Statement; the Company&rsquo;s certificate of incorporation, as amended and restated
to date; the Company&rsquo;s Bylaws as in effect on the date hereof; the Warrants; and certain resolutions and minutes of meetings of
the Board of Directors of the Company relating to the issuance of the Securities and the Registration Statement. We have considered such
matters of law and of fact, including the examination of originals or copies, certified or otherwise identified to our satisfaction, of
such records, documents, certificates, and other instruments of the Company, certificates of officers, directors and representatives of
the Company, certificates of public officials, and such other documents as in our judgment are necessary or appropriate to enable us to
render the opinion expressed below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt"></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">As to matters of fact material
to our opinions, we have relied, without independent verification, on certificates and other inquiries of officers of the Company. We
have assumed without investigation the genuineness and authenticity of all documents submitted to us as originals, the conformity to originals
of all documents submitted to us as copies thereof, and the due execution and delivery of all documents where due execution and delivery
are a prerequisite to the effectiveness thereof, the accuracy and completeness of all records made available to us by the Company, and
that all offers and sales of the Securities will be made in compliance with the securities laws of the states having jurisdiction thereof.
We have also assumed that (i) the Registration Statement and any amendments thereto (including post-effective amendments) have become
effective and will continue to be effective at the time of the resale of any Securities, (ii) if necessary, a prospectus supplement will
have been prepared and filed with the Commission describing any Securities offered thereby or any Selling Stockholders, (iii) all Securities
will be sold in the manner stated in the Registration Statement and, if necessary, the applicable prospectus supplement, and (iv) at the
time of the offering, there will not have occurred any changes in the law affecting the authorization, execution, delivery, validity or
enforceability of the Securities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The opinions set forth in
this letter are limited solely to the federal laws of the United States of America and the State of Delaware, and we express no opinion
as to the laws of any other jurisdiction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Based upon the foregoing,
and in reliance thereon, we are of the opinion that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
Shares are validly issued, fully paid and non-assessable;</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Warrants have been duly authorized by all necessary corporate action on the part of the Company and constitute the legally valid and
binding obligation of the Company, enforceable against the Company in accordance with their terms, except as may be limited by bankruptcy,
insolvency, reorganization, moratorium or similar laws relating to or affecting creditors&rsquo; rights generally (including, without
limitation, fraudulent conveyance laws) and by general principles of equity, including, without limitation, concepts of materiality,
reasonableness, good faith and fair dealing and the possible unavailability of specific performance or injunctive relief, regardless
of whether considered in a proceeding in equity or at law.</FONT></TD>
</TR></TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: left;  unicode-bidi: embed">&nbsp;</TD>
    <TD STYLE="width: 0.25in; text-align: justify;  unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</FONT></TD>
    <TD STYLE="text-align: justify;  unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon the issuance, payment for and delivery of the Warrant Shares in accordance with the applicable Warrants, the Warrant Shares will be validly issued, fully paid and non-assessable.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">We consent to the reference
to our firm under the caption &ldquo;Legal Matters&rdquo; in the Registration Statement and to the filing of this opinion as an exhibit
to the Registration Statement. In giving our consent, we do not admit that we are &ldquo;experts&rdquo; within the meaning of Section
11 of the Securities Act or within the category of persons whose consent is required by Section 7 of the Securities Act or the rules and
regulations of the Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 40%; text-align: left; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Very truly yours,</FONT></TD>
    <TD STYLE="width: 60%; text-align: left; unicode-bidi: embed">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: left;  unicode-bidi: embed">&nbsp;</TD>
    <TD STYLE="text-align: left;  unicode-bidi: embed">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; text-align: left; unicode-bidi: embed"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>/s/ Pearl Cohen Zedek Latzer Baratz LLP</B></FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>ea020247501ex23-1_actelis.htm
<DESCRIPTION>CONSENT OF KESSELMAN & KESSELMAN, CERTIFIED PUBLIC ACCOUNTANTS (ISR.) A MEMBER FIRM OF PRICEWATERHOUSECOOPERS INTERNATIONAL LIMITED, INDEPENDENT REGISTERED ACCOUNTING FIRM FOR THE COMPANY
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="text-align: right; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-style: normal; text-decoration: none"><B>Exhibit
23.1</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING
FIRM</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">We hereby consent to the incorporation by reference
in this Registration Statement on Form S-1 of Actelis Networks, Inc. of our report dated March 26, 2024 relating to the financial statements,
which appears in Actelis Networks, Inc.&rsquo;s Annual Report on Form 10-K for the year ended December 31, 2023. We also consent to the
reference to us under the heading &ldquo;Experts&rdquo; in such Registration Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1.5pt solid; width: 40%; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">/s/ Kesselman &amp; Kesselman</FONT></TD>
    <TD STYLE="width: 60%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certified Public Accountants (Isr.)</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">A member firm of PricewaterhouseCoopers International Limited</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tel-Aviv, Israel</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">March 26, 2024</FONT></TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>4
<FILENAME>ea020247501ex-fee_actelis.htm
<DESCRIPTION>FILING FEE TABLE
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 107</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Calculation of Filing Fee Tables</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Form S-1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Form Type)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Actelis Networks, Inc.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Exact Name of Registrant as Specified in its Charter)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><U>Table 1: Newly Registered Securities</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="text-align: center">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Security<BR> Type</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Security<BR> Class<BR> Title</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fee<BR> Calculation<BR> Or Carry<BR> Forward<BR> Rule</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><B>Amount<BR> Registered<SUP>(1)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid"><FONT STYLE="font-size: 10pt"><B>Proposed<BR> Maximum<BR> Offering<BR> Price Per<BR> Share<SUP>(2)</SUP></B></FONT></TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Maximum<BR> Aggregate<BR> Offering<BR> Price</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Fee<BR> Rate</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount<BR> of<BR> Registration<BR> Fee</TD><TD STYLE="padding-bottom: 1.5pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; width: 10%; text-align: left; padding-bottom: 1.5pt; text-indent: -9pt; padding-left: 9pt">Fees to Be Paid</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 11%; text-align: center; padding-bottom: 1.5pt">Equity</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 11%; text-align: center; padding-bottom: 1.5pt">Common <BR> Stock, <BR> $0.0001 par <BR> value per <BR> share (3)</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="vertical-align: top; width: 9%; padding-bottom: 1.5pt; text-align: center">457(c)</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 9%; padding-bottom: 1.5pt; text-align: right">3,697,154</TD><TD STYLE="width: 1%; padding-bottom: 4pt; text-align: left"><SUP>(3)</SUP></TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="width: 9%; padding-bottom: 1.5pt; text-align: right">1.05</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="width: 9%; padding-bottom: 1.5pt; text-align: right">3,863,525.93</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="width: 9%; padding-bottom: 1.5pt; text-align: right">0.00014760</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">570.26</TD><TD STYLE="width: 1%; padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: right; padding-bottom: 1.5pt">Total Offering Amounts</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">$</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">3,863,525.93</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">$</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">570.26</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: right; padding-bottom: 1.5pt">Total Fees Previously Paid</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 1.5pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: right; padding-bottom: 1.5pt">Total Fee Offsets</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1.5pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1.5pt solid; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1.5pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 4pt">&nbsp;</TD><TD STYLE="font-weight: bold; padding-bottom: 4pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font-weight: bold; text-align: right; padding-bottom: 4pt">Net Fees Due</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 4pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 4pt double; text-align: left">$</TD><TD STYLE="border-bottom: Black 4pt double; text-align: right">570.26</TD><TD STYLE="padding-bottom: 4pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(1)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Pursuant to Rule 416 under the Securities Act of 1933, as amended (the &ldquo;Securities Act&rdquo;), this registration statement shall also cover any additional shares of the Registrant&rsquo;s common stock that may be issued in connection with a stock dividend, stock split, recapitalization or similar transactions.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(2)</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457 under the Securities Act, based on the average of the high and low prices of the Common Stock on the Nasdaq Capital market on March 22, 2024.</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(3)</FONT></TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Consists of an aggregate of 3,396,154 that
are issuable upon exercise of warrants. All 3,697,154 ordinary shares are to be offered for resale by the selling stockholders named
in the prospectus contained in this Registration Statement on Form S-1.</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !+ 0T# 2(  A$! Q$!_\0
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MX4\)>(;C6]&OH]#U"2R:ZAD\];=BA3>,G.,8QWK[+D:WL;:6=]D4,2EW;&
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,%3ZC<3C\*]*H __9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>asns-20230930.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 26 20:52:10 UTC 2024 -->
<xs:schema elementFormDefault="qualified" xmlns:srt-types="http://fasb.org/srt-types/2023" targetNamespace="http://www.actelisnetworksinc.com/20230930" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:asns="http://www.actelisnetworksinc.com/20230930" xmlns:dtr="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="asns-20230930_lab.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="asns-20230930_pre.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef"/>
      <link:linkbaseRef xlink:type="simple" xlink:href="asns-20230930_def.xml" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrb8xOYtPeNESS0HWLdfr4iJuQUueersOTwI6y96qaPrzmCkI4XgUC/a77N1YAxjVvK6XJ/t3hMDB6r+bNGOZqdHfzyw7PpxQn2Km5H0n39AcyyD6Cfnt4QpyAwhFAmb33CAAMoNCVuONQx+2VV0p80O5MIBLHJN0mSxLkVBljD+J0FKBIm66YsrwomSAbH7ehCPDMPtd1PEHVKvY0jcfjg4e3G5BnGet5M=] CSR-->
      <link:roleType roleURI="http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd"/>
  <xs:element name="DocumentAndEntityInformationAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" substitutionGroup="xbrli:item" id="asns_DocumentAndEntityInformationAbstract"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>asns-20230930_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 26 20:52:10 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:xbrldt="http://xbrl.org/2005/xbrldt">
  <roleRef xlink:type="simple" xlink:href="asns-20230930.xsd#DocumentAndEntityInformation" roleURI="http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member"/>
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all"/>
  <definitionLink xlink:type="extended" xlink:role="http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentInformationTable" order="0" xbrldt:contextElement="segment" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="1" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="2" xbrldt:closed="true"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrb8xOYtPeNESS0HWLdfr4iJuQUueersOTwI6y96qaPrzmCkI4XgUC/a77N1YAxjVvK6XJ/t3hMDB6r+bNGOZqdHfzyw7PpxQn2Km5H0n39AcyyD6Cfnt4QpyAwhFAmb33CAAMoNCVuONQx+2VV0p80O5MIBLHJN0mSxLkVBljD+J0FKBIm66YsrwomSAbH7ehCPDMPtd1PEHRjcBdtH8VJM205B1zw79N8=] CSR-->
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="3" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentDescription" order="4" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="5" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="6" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="7" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="8" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="9" xbrldt:closed="true"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="10" xbrldt:closed="true"/>
  </definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>asns-20230930_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 26 20:52:10 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Entity Ex Transition Period</label>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrb8xOYtPeNESS0HWLdfr4iJuQUueersOTwI6y96qaPrzmCkI4XgUC/a77N1YAxjVvK6XJ/t3hMDB6r+bNGOZqdHfzyw7PpxQn2Km5H0n39AcyyD6Cfnt4QpyAwhFAmb33CAAMoNCVuONQx+2VV0p80O5MIBLHJN0mSxLkVBljD+J0FKBIm66YsrwomSAbH7ehCPDMPtd1PEHTrvgywKZWUAnQCc4H7tFO4=] CSR-->
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl0" xml:lang="en-US">Document Type</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl0" xml:lang="en-US">Entity Ex Transition Period</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl0" xml:lang="en-US">Amendment Description</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl0" xml:lang="en-US">Entity Emerging Growth Company</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl0" xml:lang="en-US">Entity Small Business</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl0" xml:lang="en-US">Entity Registrant Name</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl0" xml:lang="en-US">Amendment Flag</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl0" xml:lang="en-US">Entity Incorporation, State or Country Code</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl0" xml:lang="en-US">Entity Filer Category</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl0"/>
    <label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl0" xml:lang="en-US">Entity Central Index Key</label>
    <labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl0"/>
  </labelLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>asns-20230930_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 26 20:52:10 UTC 2024 -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <roleRef xlink:type="simple" xlink:href="asns-20230930.xsd#DocumentAndEntityInformation" roleURI="http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation"/>
  <presentationLink xlink:type="extended" xlink:role="http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation">
    <loc xlink:type="locator" xlink:label="DocumentAndEntityInformationAbstract" xlink:href="asns-20230930.xsd#asns_DocumentAndEntityInformationAbstract"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationTable"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentInformationLineItems"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="DocumentAndEntityInformationAbstract" xlink:to="dei_DocumentInformationTable" order="1.0"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationTable" xlink:to="dei_DocumentInformationLineItems" order="1.0"/>
    <loc xlink:type="locator" xlink:label="dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityRegistrantName" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_DocumentType" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
<!-- [WMV5][XcpuxYn59dz7vgYynUDuwG7r97K2jUTysl7vcz0lJt/tSeJz73kx1cLt0ZFF2SK/vxBCY0vdSrb8xOYtPeNESS0HWLdfr4iJuQUueersOTwI6y96qaPrzmCkI4XgUC/a77N1YAxjVvK6XJ/t3hMDB6r+bNGOZqdHfzyw7PpxQn2Km5H0n39AcyyD6Cfnt4QpyAwhFAmb33CAAMoNCVuONQx+2VV0p80O5MIBLHJN0mSxLkVBljD+J0FKBIm66YsrwomSAbH7ehCPDMPtd1PEHbd5cjOXvPqSta6H/mfWevs=] CSR-->
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentFlag" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_AmendmentDescription" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentDescription"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_AmendmentDescription" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFilerCategory"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityFilerCategory" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntitySmallBusiness"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntitySmallBusiness" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityExTransitionPeriod"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityExTransitionPeriod" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <loc xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_DocumentInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </presentationLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M"  UB7I80Z&?<1H#  #^"0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;(V6VW+:,!"&7T7CSO0JP0<((2EXAE/:3!O*A+2]5NP%-)$M5Y(#O'U7,A@Z
MXP@NP#KMKV]U6&U_(^2;6@-HLLUXK@;>6NOBWO=5LH:,JI8H(,>>I9 9U5B5
M*U\5$FAJC3+N1T'0]3/*<B_NV[:YC/NBU)SE,)=$E5E&Y6X$7&P&7N@=&I[9
M:JU-@Q_W"[J"!>A?Q5QBS:]54I9!KIC(B83EP!N&]Z.P;0SLB-\,-NJD3(PK
MKT*\F<IC.O "0P0<$FTD*'[>80R<&R7D^+L7]>HYC>%I^:#^8)U'9UZI@K'@
M?UBJUP.OYY$4EK3D^EELOL'>H1NCEPBN[#_95&,['8\DI=(BVQLC0<;RZDNW
M^X4X,8C:'QA$>X/(<E<36<H)U33N2[$ATHQ&-5.PKEIKA&.YV96%EMC+T$['
M$Y&4N,B:#/.43'/-](X\YM5NXZKU?8V3F*%^LA<<58+1!X)WY$GD>JU0+(7T
M?WL?X6K"Z$ XBIR""RA:I!U<D2B(V@Z]=NUQV^JUSWE\XB;Y@8/(HX9,-7E<
M"7::!<V]N5<%36#@X<50(-_!BS]_"KO!%P=NI\;MN-3C_9X\PXHI+2ERSV@&
M391NG6&B@3-%9J#ME;]"_Y.6 _"F!KQQ"M?K^;(K&KG<YHOKT!\Z,+HU1M?M
M'S*DEN.!TU43A]M>RQ(<&+<UQNV%&!-0B63%1[?HC,S3=#;!WPN9_6R1R '6
MJ\%ZEYRC,:))RG'S4]B2[[!K8G,K!4$0AITPZG4<6'<UUMTE6 ^,@R1CJF$E
M9".36V8F\FN:)!CL)6JDE9X#+PR.\3&X!'"14<[)J%38K1J#Q!F=,^<K/ G8
MX25 TPSDBN4K\A45])J,15;0O''IS@B>(XN.9-%%9%OR@H%*,1M9YR"92!NQ
MW&I+RI63ZQCP0V> CNMG+1&R$-)&_"NRT'A2B,!3)TJ\$W@U1-H8O\ZH3Z9-
MD/[)DVQVRB8>BB1FKNIUKEOKY&98/>G'X55F]$3-1BO"88FF0>L6 ZJLDHVJ
MHD5A'_A7H3%=L,4U)F@@S0#L7PJA#Q4S09WRQ?\ 4$L#!!0    ( #6)>EB?
MH!OPL0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;,!#^*T(_8&YB:N*1
M&+9 8;"-0O-A7Y58=@1Z\62Y<_KKI[-L)VEU9=V'L<VAR=T]NKM'=R>9KEMW
MDOSAR+DCO9*ZW="C<\W[)&D/1ZY8^\XT7'ND,E8QYU5;)VUC.2M;<%(R6=[<
M9(EB0M-BK3MUIUQ+#J;3;D-O:%*L*Z//EI0&@U_*%">/3&[HEDFQMV)8RY20
MIV!>@N%@I+'$>2I\0Q=@:9\"O @:L!SC**&-!6,2,H3O_;C\&3!IK5>%E#/!
M)0V&8MTPY[C5=UX9%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.<V"3J9B
M+7D%=*RHC_#K3), Z)Q17B@%JXUF X?)8Q1\V .7\@%:^*VZBMU7)/3B4PEM
M(+#52?2$1C&$"0K$OXP68E^$O?VML*01C\9][/QN]*!_[XSC]Y97HA_TOIKS
M8]$7>'36-/+T08I:*Q[V_LL)BS6;_,C16/'DL\&D'+R!6TH>N77B<&GY85FS
MX[V;IJFO<,[+?Y#SGZUSS36W3%Z2]J/_-U?Y+8R3\?1<'-&K SI;"5R$&_H5
M[E=YYD#VG9!.Z%$[BK+D^L4Y]>$=V_L+_"J^7U_RBG72[69P0\_R%UZ*3N7S
MJGNHR[CJ+'^&^VB1S;>PSR5TR7M>;D?5UOM!)%[P6<<'')XC=\,31S"?@,41
MP+ \& /,)WAA>?ZG_:S0_00,X[:*(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS
M#*OH=AMEL,7JEF7P%X^&<0,/+ ]D>ENM\6[C$_+Z'& ]?6U"L)WBDXCM%*\U
M(/&Z@4>>Q[N-Y0$/K O8[$#^>!Z8J;A/FD)7,6[8"<:1/,<0F,7XC&894IT,
M/O'^8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#
M!!0    ( #6)>EB7BKL<P    !,"   +    7W)E;',O+G)E;'.=DKENPS ,
M0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BD
MMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G
M<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^
M=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"
MR0_L?@!02P,$%     @ -8EZ6#JJHN=  0  / (   \   !X;"]W;W)K8F]O
M:RYX;6R-45UKPS ,_"O&/V!)RU98:09CW4=A;&4=?7=BI1&UK6"K[=9?/R4A
MK+"7/<DZB=/=>7&BN"^)]NK+NY *W3"W\RQ+50/>I"MJ(<BDIN@-2QMW66HC
M&)L: /8NF^;Y+/,&@[Y;C%SKF%TVQ% Q4A"P [8(I_0[[UIUQ(0E.N3O0O=O
M!UIY#.CQ#+;0N5:IH=,+13Q38.,V523G"CT9!EN(C-4?>-.)_#1EZA$VY8<1
M(86>Y4)88TS<;_3\1C0>09:'[L#TA(XA+@W#<Z1#BV'7T8B+[,)&G\-8AQ#G
M\3\Q4EUC!4NJ#AX"#SE&<)W D!ILDU;!>"CTN*+N@U6/@24DM0H#E>QV3N7T
MR@ZN6>1>9!CG*(.XLH/P4:V%&@/8-SF0!)?DJG547>EYIM<WDUM)Z.#<@V#O
MX96,'<V/'W?W U!+ P04    "  UB7I8)!Z;HJT   #X 0  &@   'AL+U]R
M96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,75@K+A %
M\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO *1;M(HN
MSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR./ /,+Q=
MZ*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W
M]T6NS>,)KM\,<'AT_@%02P,$%     @ -8EZ6&60>9(9 0  SP,  !,   !;
M0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !8T\:
MJ_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB'2)X
MKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G 8ED\
MC<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM 2D9#L9&)
M7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>,(S/N]G\
MP68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]#&DWY(%B
M6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    "  UB7I8
M!T%-8H$   "Q    $               @ $     9&]C4')O<',O87!P+GAM
M;%!+ 0(4 Q0    ( #6)>EB&O/V,[P   "L"   1              "  :\
M  !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( #6)>EB97)PC$ 8  )PG
M   3              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#
M%     @ -8EZ6$.AGW$: P  _@D  !@              ("!#@@  'AL+W=O
M<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( #6)>EB?H!OPL0(  .(,
M   -              "  5X+  !X;"]S='EL97,N>&UL4$L! A0#%     @
M-8EZ6)>*NQS     $P(   L              ( !.@X  %]R96QS+RYR96QS
M4$L! A0#%     @ -8EZ6#JJHN=  0  / (   \              ( !(P\
M 'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( #6)>E@D'INBK0   /@!   :
M              "  9 0  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+
M 0(4 Q0    ( #6)>EAED'F2&0$  ,\#   3              "  741  !;
H0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  +\2      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>10</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ea0202475-s1a2_actelis.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>asns-20230930.xsd</File>
    <File>asns-20230930_def.xml</File>
    <File>asns-20230930_lab.xml</File>
    <File>asns-20230930_pre.xml</File>
    <File doctype="S-1/A" isOnlyDei="true" original="ea0202475-s1a2_actelis.htm">ea0202475-s1a2_actelis.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>image_001.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0202475-s1a2_actelis.htm": {
   "nsprefix": "asns",
   "nsuri": "http://www.actelisnetworksinc.com/20230930",
   "dts": {
    "schema": {
     "local": [
      "asns-20230930.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd",
      "https://xbrl.sec.gov/sic/2023/sic-2023.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "asns-20230930_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "asns-20230930_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "asns-20230930_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "ea0202475-s1a2_actelis.htm"
     ]
    }
   },
   "keyStandard": 10,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2023": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 13,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 10
   },
   "report": {
    "R1": {
     "role": "http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation",
     "longName": "000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202475-s1a2_actelis.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "p",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0202475-s1a2_actelis.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Description",
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "asns_DocumentAndEntityInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.actelisnetworksinc.com/20230930",
     "localname": "DocumentAndEntityInformationAbstract",
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Ex Transition Period",
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.actelisnetworksinc.com/role/DocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001213900-24-026096-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001213900-24-026096-xbrl.zip
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M'82HM)"X21#LK]\$T&IK7Z5WVF\03I[SY#DG)R<<?0L]%\PAH0Y&92FSKTH
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M3:8P S9O"]F;,&.UF/KCY$0SSI1Y6-6'ZMPVR.@P/!^R+NP<&X9:_]ZRQ^3
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M/2O_FV342M?Y]7\24<1_4$L#!!0    ( #6)>EBORBRR@P0   L8   5
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MP?$4:48:Y@'3RQ?N 7( V#1TO$K3T. <C?3 <O/"5D[R"S(#<*9T!E(40S+
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M\$L%P!)_/^7.Z8@\EG:Q%Y/[63*.'EZ-!6.*YU,',9I,=]I @V%+SZPX\-.
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M%==S3"C)$;0 Y2,JRV2YVN@3;DJ2E3 H(%NK#2+;OJ>#WOA%D_6^ZGFGT;)
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MM*WN?_HSD+'[2<^2!YOM\N#:$!R_BTC6H@Q&P+W"FR[C[%LUSOXS[,5:4WJ
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MV#W08!6VEVT]04(>N;D@L50!FKC?8Y:OP)E;BEWU;8I& X=9\+L4(1M3@XT
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MRJ3("U0*K9ZYAKP_)F!R+BI]<FE8 I[9>9G5^A ;A=PZ6%Q>H.;X-O(7XY*
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M-ZZE)C8&Y8!5S)7/](SG2#D',0**K>G]TC>[W)LS/S5^PU(E9#W2$D.IFB-
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M5$Y8T*(7_V/QK$YF7N=9M\.%[ZLW0/\X6K;4K-%LLXNGH*K5T#%_]D]QWE=
M:$BBEF1F9@>^ZVC7<9[9#K%0*I56>-&3'MQCKO53'&V3]\RA'H>R->-.G'*Y
ML@W'O,HAR@,+51%4A-9QMN?LUK"7'JO\:N(TOH]J+]/SUD/,LXVRG#R4%@!G
MT5EM*]D@N^4]PW7CBVQS'G*UU0!760*X&S<P[!5W+EM!Z57!!6_537?2PUK:
M3X:MM$&60NNH45@H0:0?R_=C:Z.)#UN@MM:*H+>?MC]==,XZ+5+J-6H'?0U:
M_.5UEQ37RS/XK'V]29U^:Y56$9TD=J]4V>OM[S7V^:_N@)364V8;]ZCX_<H<
MAN7?6C)%'E2 <^.>FZ1%P8'P8?A %!G8UYF#(/0I&B[\*E7BQ?Y]+EP@RX'W
M8E4P7EB+S-=*+C[JK52>BPH_\M*^6"PH<"DJE6$9($<4\8I* O'"/?!BVS)Z
MHH\S%MOE1>E<WD$0M& 68%5?T\"H ]+6=30E]H=1K23^O#1(:P/+G/0M^M(D
MF(9J\)XE-FX@Z@<M?@U]&3^TW:EAPX]AN:9H>T6+0[5T4 '&40;2J-@R5N8+
M2P3RXL7ZK>N:^L! @P!\+/)3>#E&JE3KX BP.R,L)^C BGA[;/VKPRT8=Y9K
M&[(0%IPJ#2Q'5O,1XAAJU*2-0<6"OL=CQ$GBI%-2CD3N#-_\B0-?&TQL-(W(
MDE5P+2S K>GKZ@/<>A'5>X+//&:* F[^?@%!LV?=S9R*6F&9BKQ%[5Q#9%"Y
M58ISQP(7GCL.ZT 9:"EQV, 211:%F20\U*[U !O>% 5*40"[9A25;6JM.+X[
M3NPVH-M"?&M/7*9%7Y"7JR C744)5B,JQ+6=YI<-3B%6UBR.TEH]$:4BD4$6
M,(W=15Y2&>#E8(F.J(:<KU8K<WD$+A>]0URC#\U%XQG5+::F\4.J\8OQR2)A
MP3#A4_2M3;E[:JH\ Q\PQQ0AP52NBV'LL4V2/H<R9N18HO27VV>,JG&&KKL^
MW!\;H.(1H82?#!-^$):<.Z2;&I &M.S=\C_L*:'VAB/&0-,@SVT@LR+*/5%E
MM7"C]@L\*-KPHQIZ Z,O4BD(I*+XGD57]IX<=G+G9 51+"X/-QEH(V-AL=6$
MT6A'HQ?YS+LC)V @3)\\#ELVT5+/$X?5H\'D^.&HFCJJK%HS0YS)C3#V+)_)
M0C6$CV JT$*E62(S;51W#=M$H[5UZ@O*00H;;-U?$_.6PLRQ1H C*AM*\^O8
ML$0EW;"S$FPLKR_#J^GAI@.SG48685F_5NYY2E7<12B2&4(:/1ENU**#,OJB
M!(W"A43E>ZQJ#Q/P%!ZM3KP'W)S=A8D\EB/]SNX84W;P[]H,!D+BV\.SCJJP
MPX"%.8NXO /*"F&OAP;FJD3SP"I'$Y[<)"84Y:_P.8?2@&2>"#_)FHIZ,R(L
MZ40DI!94U5<R02OSE>-%^G@%=& B>,*F+)0>VNAYDH$<7-8OQ<2(L/L+[A7F
M3P (+4HH,,9X]EBX.\S3PPFK\Z6JIR;"5IZ9ALP]JG^HS+.H_X%BFW+=9]\$
M",.6"\C=12'E$?" ("J;CGV\PI0,-L![)5.$Q([QBE.<L!H]]XX5YK:+2AY%
MQS"T1OA^O-_&+;+2(,.5%65O"/L^5NY,OI":O) _/%=.DIH424>;E71B0I3^
M;HHEA<.,PP$O,QV#=$RBQ"^'UTP@$M!E,SID2O&+\"]<7_+F:N?4]FBWO;Z9
MJE?6E^2V[&1J2Z=S\*CLECRY9<NASRU'>KE>U*_;K?;%C=YMGK>[:#'Z?''=
M_K73O6EC)$BWW?I\W;GIM'.3T5R<@YHIZ;$Q-O3 I@AJ9Q ,LIL);XB:. "P
M_8!4'48ELV13DWN4$U#L4PJZIY4B_N%9ZK.EWUXZ87$S:?Z1%<[NF49$EM0
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M:)#X:HAM+05<.7E]6>1U$=NWGHCQXZ7TT#J5A>VKE([N(=P.O)PR5'B,59(
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M4;6([\8^48R'P =PQGP6#N&,4NB1OD_E*PKUC(L NGO%7Q#2CO'5FT1T]Y6
MUW05]9DVH\9<?,/AGT(W_RN@;-\05\$%":@FZ!4=,JD$"140"=V(NFS J <L
M!*8DM$9$X+#7@?J7AEF#4#S6=OQ)$CP5&&^7NK%@BND5^B6[>S 36J]Y<MZ&
M5OO\O-,\/?UT\<^'7"%GVMU.LY6V$Z=]+CPJ]ESN^R22%$-)CFHP9IX:Z0D5
MMFJPBJ+K;>(J=7!-A6(N\5.H^EPI'N22#:7>.TT[/G;3>J>-J9YZ+GMCJF5>
MV_.]&D3$\U %]ZQUG&B^&JE[XV?\S;$R.X4:) "EAD]\XGZSYD%RGWFY1G)?
M)_63JX81D#]IOBV?2&EGSI2?]=1;EYIS%Q]RI5SF8>"&9R.XVPY-^U+@*2%L
M>"CJ8R(\<WP5S\8W-QC+]GN37!,5UXE/_>SRHG?/JF0_J%W#=G\(>!PJ"\VM
M2M6[7SJ-G2*JL3ZPFX4VU-@@=X=<1_"(2VII]9G<L" .+/<& Q3!<&@:'<%<
M"ATJ3*N+VQRUZ);^:G2G\6H.AX(.B:(+T/N+8$GE[$JC\?>$/25"?#"E1>).
MT#4RF0"RW[M:+CO!B>-$AP*GYNG4B M\JASV=TJ%BE,JOW=*U>KNG SFH3'%
MHZDL:NL^1#X=J 6W(>G(0H_JI&OO*)KJJ<<=PY&^60B,1"=P@BI#F/<0I-3S
MUK/2C4>#*6[-O]\+_+2_QSK?>+'S:_$@P(=IJ].*N]\<>_RND"\4"D4<)NR)
M:^+'%"*:-*76=-@I[V8;VE.C9XFT:.$_!M+1<N;35+Q2/=QQ5PYT^:F^%,A6
M0R?YK:GL'!P=.L5J986H*O-G95.$\FV*\+M1>I<)0,5\H?J:N),-*F7G_4'9
MJ9:J^:/R!IV'Z%CQK1P>%/X ;)[*=%:%:35["6+5PT*^=) U6C^5-OT[8HK.
MR96>1GL-^6NQL&P":P!=Z*7'%?%O'U? YK!RR21U66H^@X_K\#B7:,\>_[L"
MGEEJV8CT"X[XM=SB3(0U0S7]]1*ZQ)/G*U!3\S#;$?2:\5CZD[E/M)OEM@EX
M$_!O$-3YSI^EJMN!1^0H&QPVF>E"+=79J:2;I'03\";@C82^G,RT\E-:^G#T
M.I34^+B@RF:DI_&3+Y\6_)"['-L61[0F;S^QL#:!;@)=)="YXH:CP.-QWZ?/
M?W)?9&.E!_<E8K\5QWU34[?V>KWI^KR']7LK.YTJWWNR*$_Q:(YV)Q80S"H+
MGRJ+,35#=[4LCY;W_1=+Q0:3ITQV8B%C73:JN"G>@DKQ '#[H0+4B$[54T+3
M5;K2M'A4+CNZR)0$%+MYL*/[;?O>]YC7[G??%N;DKH.FF 0Q570 4A%%T8+2
M+WA]'X@O.;@<00,23D#S2/?#1-N\ );:M79T5^BZ+:2V+G&4>;,L]4ME[$,4
M<F$"?0I,RMC6P+H\#*EK'(^9&@%)>GOLFGD8AI.T9>0SY>!,71(QS/+9CZ0$
M7(!D ?,)HH*^)3&V9/Y>9=$LDS.H@)U-",;VF>IU$KR4.<';V"M KGDZV:/^
M! ;<4CN*A2XPT\1"!D6QTJ\9] 5B7C6DA+O'V@$UXQZLF.KAPA7CX V4Z!O'
M&M.(&1G2U/8(M13I[H'/QQ#I8JQ;GB?E$J92(AU]0:1'OD/+<E,SY1NF4'CQ
M,Q'N"$HE!TJ%4F7#RJQ969[/RO0HVSKW6UZW4&&0>H82) 22UO'I=MDI'QWH
M8@@C>&_?Z!H9+7>F,#Z.D!/TA@J767Z/B="**?/01*F]+:1 6</=FHA)JK':
M"K*ZKP<-3#V]7BQXA:#5_L204%+?? MC!'.$"3\5$D+<#+RW;YCE:22XC%!N
M8ZW-H2(LM"IL=H'ITC.D=[H+8"/]$"6OZ?,"R+NOO[:RGU_IK[3^!U!+ P04
M    "  UB7I8,8_A/2,#   S"P  '0   &5A,#(P,C0W-3 Q97@R,RTQ7V%C
M=&5L:7,N:'1MU5;?;],P$'ZOU/_A%&D52.O/ 0]M5BE-,JCHVJH-0GMT4Z<Q
M.':PG77EK^?<- /&$&RL"/J0U/;==]]W]EWLOHDN)\-ZS7T3>@&^P?[<:!Q-
MPJ';+M^XVCXLNZ-9< 7+Z&H2GCN)%*8/W4YN(&(9U3"E6UC(C(C3<N(4EE2Q
MQ$%'=)U7?H;>F";A;"/ZH-@F-0/X7:@!9$1M&#I:TXXS="]FT^A;0DUM=ISV
M04B5$3Z ?; UC:4BADEA%P1%O]$PO$G9BIEZK7?6ZKKM$>JU8/B:WR'\>':C
M84.L=#XHX9\(]R#JD,&8"D.5,_1GTV6(N9A=P'@:A/,0'SA<A*_'RRA<A ',
MWXTF8Q\\WY^]FT;CZ>MZ[6*\N#PRKRH!1PGRH="&)3MG^)Y"2A5=[2"60F-H
M,!),2H$)W/K\L/N ZXHF:"AB6J\Q@29,PX)NF#8'DZ4AAF86 0<7>(I@V>R"
M3,"+#>7,\C1;J3XBO[&(6W9%%@IA,8B!-3JOX9*H.(7>JU/H=7HO<(TCMMA4
MG!(FB(@9X:"K8/JT7MNF#+U(GE.B-!+_2<2&TI\*.=#@"5$@QJ*,7+'M=IIO
ML9[4/M(.H8"*-7(*:$RS%55PUMW3.FL!)HUP+>^DK%Z[39&=*304"%#BI92L
MK9 &7UL.X4U.E=$-M1]9RKI "??GLW7L,W#GI$7>:!*"'TXFR[GGXW$_=SK.
M?CSW@J :/YC)EJU-:DT[)P-8286I:<:2<Y)K;#O5/V??2]UH406XQD2QF/"*
MM9&Y<^BW;A145@>\E31&9GT8<1)_A&[K)=+2DK/U;?@7-GK9[]AG6C*_KQLF
M)&-\U_^5J!^0VKH-;ZG6E*,U-$B6#[Z.;QME%/PHX4#P5>?DZXZ@'3X6C\O)
M$57ZED#"L#KFQ8JS&"LNEH4P! L2GHVU:CV_5^L?"O-G]DA.SYV>\Q=$>I"5
MA9\P; _8KN:*Q72+5:E266CJ2XE5K+&WX(S8%RUVE0G+&+:R;^7_DUM8[<33
M[]+QN4>4-[UK=HU]72M"^?^IXON/W0,TM/<=^LGN6D]W;;OS(6G;2V]Y"[:7
MY2]02P,$%     @ -8EZ6#!RHW>5#   /S4  !P   !E83 R,#(T-S4P,65X
M-2TQ7V%C=&5L:7,N:'1M[5MM3]O(%OX>*?]A+KJW:B4'$EX+9)&@T-U*=!=!
M=E=[OTWL23*M8[LS-C3]]?<Y9VS'3IQ V5)4[>V'0NR9<Y[S,N=M0O^7P?O+
MDW:K_\O%Z3E^"OK7'[P;7%Z<]+?<3[S=RE_WSWX[_TO<#/ZZO/AI8Q1'Z9'H
M=9-4#/146?&KNA/7\51&GGO@B1ME]&@#&['UJMB7JL]I1X9Z'!T)H\>3]%A,
MI1EK?.QNG/3/3BX^3_10IV)OL]??.@..JP4*E>4OHJ%-CI>7/!1<A3>6=H]%
M%5VH1NG&R7MI_(G8WO?$=G=[]TE9?0=I3OU4A9HHI'>Q^6@]Q_-=Y&_VSZ[!
M=[>[<RC>A#I)E!%OXLRD3XKGK5%34//$FU-QN+OW>N='5_"U.A+7:JQM:F2J
MXTC<I#)54Q6E A_>QF8J;CJ]K=,?7<Y+&6@0D%$@?H9P(8EX](0<\R<Z"A11
MW#W8[.XE3RWJA\RF>C1;X-W=W-/1QLF?2DSDK1(21RH0T@H_SB*K0I'&[=;2
M.1-TQ#PAQ;D*Y9TT"LM-$N=.\C*=*/$B##YE\3%"X)MXFLAH1N'OA>&'KSRA
M(VR)(N7SCCN=3@3M6N]L[19[FQCI$""',]Z2DQ<9!#+\Y$;YF=$I613(13P2
MO<.='8^DDB 78.\"Q/J..M(2V^^1)MTP*@LH\SWD-Q>?_8F,QHQGJJUM5D3^
MILJ!A*-U <B*B3(*>!<V-FNE2F2SW1JL5I^!E8 9MF1.\6@$9XG&C-O*4(F1
MB:<BA2/Q$OH)$%E"GW:\_<,#K[>W*^P$AK;TIJ+V%\82 /*7*6)?NV73V/_H
MB7]W-[O=;D\DTHA;&69*4 AF$N)E724,%9OJ:L^M"Q<,"2J3G<0A;&R%)M?5
M(PUKZ&B-W[1;2W9VU&XJU&JV@$]:$*(U9 ;]2NQT>QXDJ4A?Q;QHJ7/EJ^D0
MDB*][H@;WE-ET&[! 3*'6XK$Z%NR>A)*WUD*C^LDUM*_RO=?%?OK*GRI@;_G
M;1_TO-[K@R4)X,(L B&20WA!EN2NJ#XKXVO+7H#3;624VJK5ZBC^S%?4%#D7
MDPC> WO)3HT,&M3),D+(PX-NHXCB(1(F1G5&&8>%0E@ 6JUSU7GK5O]]P>\S
M;\&JW5JO@]M78F]OG9M^O8UO5)+>8^2J,R\L7SIW3<2:A8$LA[N[WO[!ZC,W
M)_Q>SICD.@4]0OB"['TF;CC"4$HDROT+>BB?WW=R;^'4KU][AZ]W'NG3<SAR
M3(YV_S&^.KU/VJ:$_4@';[<6>"[;S>/T!$U %?O[7F_[L<>[Q+*H":QLMYJ,
MTZ@)AR>-QPK[S%P#2[[B+1Z&^8M[0XG7;I5K*C"8=7/4]41=PX^PX6JO7 K,
M51VML-BRAE;Y64YAE;[*UXM.LZ2V<F63/<J7*W58V[ZDR<8L_A!!FZFZISDE
M(KI*:^O!S:O/6AGX'*W#\S4M[YK\&7U*G.@(3W"8[O*V1GV64QU19P-=HQRF
MTK&,%LW%XW%SF:L,59X^'1,$%QU5&I]:A^$86:*&](U"FNK[9IIG,S11EC;C
M@"H4YW[:T!0<5[W"'C,#0B.Q"8SB,",,+E1 UBQUD7*J%)6S]#M@@,)9+$U
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MES%VB?:RT$\<0?^@T)@:JF]G<&'KK0WR.=3]KX!:R6SS4/>U*OH6:?01-*J
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M]J<K\)KI ?_*O>TU*>'92+;!7O=K,HMJU\W5ISELGL4'B,6F?_2"$WLF^1E
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M"$(.K],S1U$<HQ12!@.X'WPUGL3/O6)V?NZ0M%6Y!29A%2RD&][-/&L7*\Z
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MER9&E,]P&164!ZF]7-KS?O9^0>3+!&0[[T!U;NH$Q62()G4+K:[[O=+GMUX
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M\FDLM>L8VKR73SO+2_U KC>7F3'R;U!+ 0(4 Q0    ( #6)>E@JVYK9:00
M  P-   1              "  0    !A<VYS+3(P,C,P.3,P+GAS9%!+ 0(4
M Q0    ( #6)>E@![MNQTP0  )<8   5              "  9@$  !A<VYS
M+3(P,C,P.3,P7V1E9BYX;6Q02P$"% ,4    "  UB7I8-S97PR\%  #()0
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M,5]A8W1E;&ES+FAT;5!+ 0(4 Q0    ( #6)>E@P<J-WE0P  #\U   <
M          "  <>R  !E83 R,#(T-S4P,65X-2TQ7V%C=&5L:7,N:'1M4$L!
M A0#%     @ -8EZ6,+X&2_,$P  RA0   T              ( !EK\  &EM
A86=E7S P,2YJ<&=02P4&      D "0!K @  C=,

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>ea0202475-s1a2_actelis_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="asns-20230930.xsd" xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001141284</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-09-30</endDate>
        </period>
    </context>
    <dei:AmendmentDescription contextRef="c0" id="ixv-43">AMENDMENT NO. 2</dei:AmendmentDescription>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-67">Actelis Networks, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c0" id="ixv-91">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFilerCategory contextRef="c0" id="ixv-240">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c0" id="ixv-250">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c0" id="ixv-263">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="c0" id="ixv-3452">false</dei:EntityExTransitionPeriod>
    <dei:DocumentType contextRef="c0" id="hidden-fact-0">S-1/A</dei:DocumentType>
    <dei:AmendmentFlag contextRef="c0" id="ixv-3456">true</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-3457">0001141284</dei:EntityCentralIndexKey>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.1</span><table class="report" border="0" cellspacing="2" id="idm140561781363024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th" colspan="1">9 Months Ended</th>
</tr>
<tr><th class="th"><div>Sep. 30, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Actelis Networks, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">S-1/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentDescription', window );">Amendment Description</a></td>
<td class="text">AMENDMENT NO. 2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001141284<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of changes contained within amended document.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
